ONTOLOGY REPORT - ANNOTATIONS
| Term: | arsenic atom |
|
| Accession: | CHEBI:27563
|
browse the term
|
| Definition: | A pnictogen that has formula As. |
| Synonyms: | related_synonym: | 33As; Arsen; Arsenic; As; InChI=1S/As; InChIKey=RQNWIZPPADIBDY-UHFFFAOYSA-N; arsenico; arsenicum |
| | alt_id: | CHEBI:22630; CHEBI:2845 |
| | xref_casrn: | 7440-38-2 |
| | xref: | ChemIDplus:7440-38-2 "CAS Registry Number"; KEGG COMPOUND:7440-38-2 "CAS Registry Number"; KEGG COMPOUND:C06269 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D001151 |
| | xref: | WebElements:As "WebElements" |
|
|
arsenic atom
|
| G |
Aar2 |
AAR2 splicing factor homolog (S. cerevisiae) |
|
increases methylation |
ISO |
3 |
146,962,602 |
146,983,950 |
RGD:6480464 |
CTD |
| G |
Aass |
aminoadipate-semialdehyde synthase |
|
decreases expression |
ISO |
4 |
49,479,938 |
49,539,782 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases export |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases activity |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases export |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases expression |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abhd17a |
abhydrolase domain containing 17A |
|
affects expression |
ISO |
7 |
10,635,489 |
10,641,920 |
RGD:6480464 |
CTD |
| G |
Acer3 |
alkaline ceramidase 3 |
|
decreases expression |
ISO |
1 |
155,455,466 |
155,556,319 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
increases activity |
ISO |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Acta1 |
actin, alpha 1, skeletal muscle |
|
decreases expression |
EXP |
19 |
54,081,496 |
54,084,508 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
EXP |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Adam10 |
ADAM metallopeptidase domain 10 |
|
decreases expression |
ISO |
8 |
75,200,657 |
75,289,572 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
decreases expression |
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases methylation |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Aes |
amino-terminal enhancer of split |
|
affects expression |
ISO |
7 |
9,616,545 |
9,621,697 |
RGD:6480464 |
CTD |
| G |
Aff1 |
AF4/FMR2 family, member 1 |
|
increases expression |
ISO |
14 |
7,015,191 |
7,114,671 |
RGD:6480464 |
CTD |
| G |
Aff4 |
AF4/FMR2 family, member 4 |
|
increases expression |
ISO |
10 |
38,798,873 |
38,883,154 |
RGD:6480464 |
CTD |
| G |
Ahctf1 |
AT hook containing transcription factor 1 |
|
affects expression |
ISO |
13 |
95,432,560 |
95,483,323 |
RGD:6480464 |
CTD |
| G |
Ahcy |
adenosylhomocysteinase |
|
increases expression |
ISO |
3 |
145,544,834 |
145,560,058 |
RGD:6480464 |
CTD |
| G |
Ahcy |
adenosylhomocysteinase |
|
multiple interactions |
ISO |
3 |
145,544,834 |
145,560,058 |
RGD:6480464 |
CTD |
| G |
Akap9 |
A kinase (PRKA) anchor protein (yotiao) 9 |
|
decreases expression |
ISO |
4 |
26,772,929 |
26,803,149 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
increases expression |
EXP |
4 |
61,714,282 |
61,726,856 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
increases methylation |
ISO |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
affects expression |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Anapc16 |
anaphase promoting complex subunit 16 |
|
increases methylation |
ISO |
20 |
27,287,617 |
27,301,901 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
decreases expression |
ISO |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Ankrd10 |
ankyrin repeat domain 10 |
|
affects expression |
ISO |
16 |
82,719,075 |
82,742,218 |
RGD:6480464 |
CTD |
| G |
Ano1 |
anoctamin 1, calcium activated chloride channel |
|
increases methylation |
ISO |
1 |
205,018,529 |
205,166,049 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
increases expression |
EXP |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
affects expression |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Ap3d1 |
adaptor-related protein complex 3, delta 1 subunit |
|
affects expression |
ISO |
7 |
10,480,810 |
10,516,163 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
increases expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
|
affects expression |
ISO |
1 |
163,282,918 |
163,299,333 |
RGD:6480464 |
CTD |
| G |
Apc2 |
adenomatosis polyposis coli 2 |
|
affects expression |
ISO |
7 |
10,903,675 |
10,920,010 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
affects response to substance |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
affects response to substance |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Aplnr |
apelin receptor |
|
decreases expression |
ISO |
3 |
68,365,637 |
68,369,282 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
increases response to substance |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
decreases expression |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Arf2 |
ADP-ribosylation factor 2 |
|
decreases expression |
ISO |
10 |
93,114,540 |
93,136,313 |
RGD:6480464 |
CTD |
| G |
Arg2 |
arginase type II |
|
decreases expression |
ISO |
6 |
101,901,653 |
101,928,282 |
RGD:6480464 |
CTD |
| G |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
|
increases response to substance |
ISO |
8 |
45,984,042 |
46,106,412 |
RGD:6480464 |
CTD |
| G |
Arid3c |
AT rich interactive domain 3C (BRIGHT-like) |
|
increases methylation |
ISO |
5 |
59,148,421 |
59,154,267 |
RGD:6480464 |
CTD |
| G |
Arih2 |
ariadne homolog 2 (Drosophila) |
|
affects expression |
ISO |
8 |
113,647,000 |
113,705,922 |
RGD:6480464 |
CTD |
| G |
Arpc2 |
actin related protein 2/3 complex, subunit 2 |
|
increases methylation |
ISO |
9 |
73,563,617 |
73,594,263 |
RGD:6480464 |
CTD |
| G |
Arsj |
arylsulfatase family, member J |
|
increases methylation |
ISO |
2 |
223,574,825 |
223,666,259 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
increases methylation |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
increases methylation |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects metabolic processing |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects metabolic processing |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects metabolic processing |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
increases methylation |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
multiple interactions |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects metabolic processing |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects response to substance |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects methylation |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects response to substance |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
increases methylation |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
increases metabolic processing |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects metabolic processing |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects metabolic processing |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
multiple interactions |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects response to substance |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
multiple interactions |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
increases methylation |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
multiple interactions |
EXP |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects methylation |
EXP |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
increases methylation |
EXP |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
Asic3 |
acid-sensing (proton-gated) ion channel 3 |
|
increases methylation |
ISO |
4 |
6,125,614 |
6,129,660 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
decreases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atl3 |
atlastin GTPase 3 |
|
affects expression |
ISO |
1 |
210,177,817 |
210,219,558 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
decreases expression |
ISO |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
|
affects expression |
ISO |
13 |
46,631,205 |
46,697,214 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
increases expression |
ISO |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Atp5g1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) |
|
affects expression |
ISO |
10 |
84,788,650 |
84,791,230 |
RGD:6480464 |
CTD |
| G |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
decreases expression |
ISO |
14 |
42,923,309 |
43,165,666 |
RGD:6480464 |
CTD |
| G |
Atxn1 |
ataxin 1 |
|
affects expression |
ISO |
17 |
24,719,383 |
25,138,270 |
RGD:6480464 |
CTD |
| G |
Atxn7 |
ataxin 7 |
|
decreases expression |
ISO |
15 |
12,669,541 |
12,758,262 |
RGD:6480464 |
CTD |
| G |
Auts2 |
autism susceptibility candidate 2 |
|
affects expression |
ISO |
12 |
25,518,248 |
25,541,023 |
RGD:6480464 |
CTD |
| G |
Bag3 |
Bcl2-associated athanogene 3 |
|
affects expression |
ISO |
1 |
187,781,147 |
187,804,835 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcdin3d |
BCDIN3 domain containing |
|
increases methylation |
ISO |
7 |
138,218,542 |
138,223,136 |
RGD:6480464 |
CTD |
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
increases expression |
ISO |
2 |
244,116,880 |
244,126,393 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
|
decreases response to substance |
ISO |
4 |
144,139,486 |
144,145,186 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
decreases expression |
ISO |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
increases expression |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Blk |
B lymphoid tyrosine kinase |
|
multiple interactions |
ISO |
15 |
42,643,847 |
42,682,793 |
RGD:6480464 |
CTD |
| G |
Blm |
Bloom syndrome, RecQ helicase-like |
|
decreases expression |
ISO |
1 |
136,271,573 |
136,358,077 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
increases expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
decreases expression |
ISO |
8 |
80,593,053 |
80,717,015 |
RGD:6480464 |
CTD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
decreases expression |
ISO |
9 |
58,327,587 |
58,436,057 |
RGD:6480464 |
CTD |
| G |
Bok |
BCL2-related ovarian killer |
|
increases expression |
ISO |
9 |
92,970,069 |
92,980,974 |
RGD:6480464 |
CTD |
| G |
Bpifa1 |
BPI fold containing family A, member 1 |
|
increases expression |
ISO |
3 |
144,529,855 |
144,535,598 |
RGD:6480464 |
CTD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
decreases expression |
ISO |
4 |
67,117,759 |
67,243,058 |
RGD:6480464 |
CTD |
| G |
Bre |
brain and reproductive organ-expressed (TNFRSF1A modulator) |
|
affects expression |
ISO |
6 |
24,406,837 |
24,791,918 |
RGD:6480464 |
CTD |
| G |
Brf2 |
BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like |
|
increases methylation |
ISO |
16 |
69,250,416 |
69,255,138 |
RGD:6480464 |
CTD |
| G |
Bst1 |
bone marrow stromal cell antigen 1 |
|
decreases expression |
ISO |
14 |
72,404,263 |
72,414,500 |
RGD:6480464 |
CTD |
| G |
Btaf1 |
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, (Mot1 homolog, S. cerevisiae) |
|
increases methylation |
ISO |
1 |
241,212,431 |
241,287,889 |
RGD:6480464 |
CTD |
| G |
Btbd3 |
BTB (POZ) domain containing 3 |
|
increases methylation |
ISO |
3 |
126,403,030 |
126,409,372 |
RGD:6480464 |
CTD |
| G |
Btnl7 |
butyrophilin-like 7 |
|
affects expression |
ISO |
20 |
4,437,293 |
4,447,525 |
RGD:6480464 |
CTD |
| G |
C1s |
complement component 1, s subcomponent |
|
increases expression |
EXP |
4 |
160,736,133 |
160,748,133 |
RGD:6480464 |
CTD |
| G |
C2cd3 |
C2 calcium-dependent domain containing 3 |
|
affects expression |
ISO |
1 |
157,774,397 |
157,892,744 |
RGD:6480464 |
CTD |
| G |
Calcrl |
calcitonin receptor-like |
|
decreases expression |
ISO |
3 |
67,553,022 |
67,646,877 |
RGD:6480464 |
CTD |
| G |
Camp |
cathelicidin antimicrobial peptide |
|
affects expression |
ISO |
8 |
114,214,914 |
114,216,728 |
RGD:6480464 |
CTD |
| G |
Capg |
capping protein (actin filament), gelsolin-like |
|
decreases response to substance |
ISO |
4 |
105,850,321 |
105,862,109 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
increases expression |
ISO |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car6 |
carbonic anhydrase 6 |
|
affects expression |
ISO |
5 |
167,332,219 |
167,350,880 |
RGD:6480464 |
CTD |
| G |
Card10 |
caspase recruitment domain family, member 10 |
|
increases expression |
ISO |
7 |
116,737,928 |
116,766,959 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
increases expression |
ISO |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
decreases expression |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
multiple interactions |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases response to substance |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbs |
cystathionine beta synthase |
|
increases expression |
ISO |
20 |
10,047,478 |
10,075,520 |
RGD:6480464 |
CTD |
| G |
Cbs |
cystathionine beta synthase |
|
affects metabolic processing |
ISO |
20 |
10,047,478 |
10,075,520 |
RGD:6480464 |
CTD |
| G |
Cbs |
cystathionine beta synthase |
|
affects metabolic processing |
ISO |
20 |
10,047,478 |
10,075,520 |
RGD:6480464 |
CTD |
| G |
Cbs |
cystathionine beta synthase |
|
affects response to substance |
ISO |
20 |
10,047,478 |
10,075,520 |
RGD:6480464 |
CTD |
| G |
Ccbp2 |
chemokine binding protein 2 |
|
decreases expression |
ISO |
8 |
127,026,528 |
127,028,214 |
RGD:6480464 |
CTD |
| G |
Ccdc150 |
coiled-coil domain containing 150 |
|
increases methylation |
ISO |
9 |
53,085,922 |
53,172,920 |
RGD:6480464 |
CTD |
| G |
Ccdc59 |
coiled-coil domain containing 59 |
|
affects expression |
ISO |
7 |
44,496,241 |
44,502,624 |
RGD:6480464 |
CTD |
| G |
Ccdc68 |
coiled-coil domain containing 68 |
|
increases methylation |
ISO |
18 |
66,623,573 |
66,665,814 |
RGD:6480464 |
CTD |
| G |
Ccdc68 |
coiled-coil domain containing 68 |
|
decreases expression |
ISO |
18 |
66,623,573 |
66,665,814 |
RGD:6480464 |
CTD |
| G |
Ccdc85a |
coiled-coil domain containing 85A |
|
decreases expression |
ISO |
14 |
109,197,317 |
109,434,306 |
RGD:6480464 |
CTD |
| G |
Ccl1 |
chemokine (C-C motif) ligand 1 |
|
decreases expression |
ISO |
10 |
70,380,498 |
70,383,276 |
RGD:6480464 |
CTD |
| G |
Ccl1 |
chemokine (C-C motif) ligand 1 |
|
multiple interactions |
ISO |
10 |
70,380,498 |
70,383,276 |
RGD:6480464 |
CTD |
| G |
Ccl19 |
chemokine (C-C motif) ligand 19 |
|
decreases expression |
ISO |
5 |
59,221,738 |
59,223,682 |
RGD:6480464 |
CTD |
| G |
Ccl19 |
chemokine (C-C motif) ligand 19 |
|
multiple interactions |
ISO |
5 |
59,221,738 |
59,223,682 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases response to substance |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
decreases expression |
ISO |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccl21 |
chemokine (C-C motif) ligand 21 |
|
multiple interactions |
ISO |
5 |
59,238,897 |
59,240,001 |
RGD:6480464 |
CTD |
| G |
Ccl21 |
chemokine (C-C motif) ligand 21 |
|
decreases expression |
ISO |
5 |
59,238,897 |
59,240,001 |
RGD:6480464 |
CTD |
| G |
Ccl22 |
chemokine (C-C motif) ligand 22 |
|
decreases response to substance |
ISO |
19 |
10,697,324 |
10,704,129 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
decreases expression |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
decreases expression |
ISO |
10 |
71,759,643 |
71,761,115 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
EXP |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
increases expression |
ISO |
2 |
144,275,211 |
144,285,196 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
increases expression |
ISO |
5 |
36,465,490 |
36,483,538 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
increases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
decreases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccno |
cyclin O |
|
increases methylation |
ISO |
2 |
44,377,953 |
44,381,020 |
RGD:6480464 |
CTD |
| G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
multiple interactions |
ISO |
8 |
128,693,658 |
128,699,213 |
RGD:6480464 |
CTD |
| G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
decreases expression |
ISO |
8 |
128,693,658 |
128,699,213 |
RGD:6480464 |
CTD |
| G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
decreases expression |
ISO |
8 |
128,693,658 |
128,699,213 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
decreases expression |
ISO |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
multiple interactions |
ISO |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
decreases expression |
ISO |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
|
decreases expression |
ISO |
8 |
115,451,786 |
115,454,088 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd177 |
CD177 molecule |
|
increases expression |
ISO |
1 |
80,033,098 |
80,053,738 |
RGD:6480464 |
CTD |
| G |
Cd247 |
Cd247 molecule |
|
affects expression |
ISO |
13 |
81,515,383 |
81,594,699 |
RGD:6480464 |
CTD |
| G |
Cd300lb |
CD300 molecule-like family member b |
|
decreases expression |
ISO |
10 |
104,825,709 |
104,835,698 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
decreases expression |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd40lg |
CD40 ligand |
|
multiple interactions |
ISO |
X |
141,925,019 |
141,937,183 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
decreases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd69 |
Cd69 molecule |
|
affects expression |
ISO |
4 |
166,527,683 |
166,535,601 |
RGD:6480464 |
CTD |
| G |
Cd83 |
CD83 molecule |
|
decreases expression |
ISO |
17 |
26,705,646 |
26,725,470 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
decreases expression |
EXP |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
affects expression |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdcp1 |
CUB domain containing protein 1 |
|
affects expression |
ISO |
8 |
127,951,811 |
127,988,666 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
decreases expression |
ISO |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cdh16 |
cadherin 16 |
|
affects expression |
ISO |
19 |
279,359 |
289,543 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk5 |
cyclin-dependent kinase 5 |
|
increases expression |
ISO |
4 |
6,119,704 |
6,124,186 |
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
increases expression |
ISO |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases methylation |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cel |
carboxyl ester lipase |
|
affects expression |
ISO |
3 |
7,541,127 |
7,549,245 |
RGD:6480464 |
CTD |
| G |
Cenpe |
centromere protein E |
|
increases methylation |
ISO |
2 |
232,699,627 |
232,758,329 |
RGD:6480464 |
CTD |
| G |
Cenpl |
centromere protein L |
|
affects expression |
ISO |
13 |
76,629,572 |
76,644,429 |
RGD:6480464 |
CTD |
| G |
Cep72 |
centrosomal protein 72 |
|
affects expression |
ISO |
1 |
30,031,815 |
30,061,725 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
increases expression |
ISO |
7 |
11,325,538 |
11,327,261 |
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
affects expression |
ISO |
1 |
208,133,876 |
208,137,408 |
RGD:6480464 |
CTD |
| G |
Chd2 |
chromodomain helicase DNA binding protein 2 |
|
affects expression |
ISO |
1 |
128,609,727 |
128,720,325 |
RGD:6480464 |
CTD |
| G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
|
decreases expression |
ISO |
4 |
161,217,964 |
161,251,018 |
RGD:6480464 |
CTD |
| G |
Chdh |
choline dehydrogenase |
|
affects metabolic processing |
ISO |
16 |
5,349,304 |
5,380,800 |
RGD:6480464 |
CTD |
| G |
Chml |
choroideremia-like (Rab escort protein 2) |
|
affects expression |
ISO |
13 |
91,420,770 |
91,422,635 |
RGD:6480464 |
CTD |
| G |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing 1 |
|
increases methylation |
ISO |
8 |
15,732,905 |
15,759,297 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
decreases expression |
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
multiple interactions |
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cideb |
cell death-inducing DFFA-like effector b |
|
multiple interactions |
ISO |
15 |
33,916,472 |
33,920,872 |
RGD:6480464 |
CTD |
| G |
Cideb |
cell death-inducing DFFA-like effector b |
|
decreases expression |
ISO |
15 |
33,916,472 |
33,920,872 |
RGD:6480464 |
CTD |
| G |
Clca1 |
chloride channel accessory 1 |
|
decreases expression |
ISO |
2 |
243,057,135 |
243,084,146 |
RGD:6480464 |
CTD |
| G |
Clca2 |
chloride channel accessory 2 |
|
decreases expression |
ISO |
2 |
243,114,775 |
243,142,349 |
RGD:6480464 |
CTD |
| G |
Clec4d |
C-type lectin domain family 4, member D |
|
decreases expression |
ISO |
4 |
159,883,556 |
159,892,609 |
RGD:6480464 |
CTD |
| G |
Clec4e |
C-type lectin domain family 4, member E |
|
decreases expression |
ISO |
4 |
159,901,953 |
159,907,090 |
RGD:6480464 |
CTD |
| G |
Clic5 |
chloride intracellular channel 5 |
|
decreases expression |
ISO |
9 |
12,370,341 |
12,472,969 |
RGD:6480464 |
CTD |
| G |
Clp1 |
cleavage and polyadenylation factor I subunit 1 |
|
increases methylation |
ISO |
3 |
67,934,068 |
67,937,772 |
RGD:6480464 |
CTD |
| G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
|
affects expression |
ISO |
8 |
119,209,101 |
119,265,441 |
RGD:6480464 |
CTD |
| G |
Col24a1 |
collagen, type XXIV, alpha 1 |
|
increases methylation |
ISO |
2 |
243,490,052 |
243,727,759 |
RGD:6480464 |
CTD |
| G |
Col4a3 |
collagen, type IV, alpha 3 |
|
decreases expression |
ISO |
9 |
81,910,656 |
82,036,998 |
RGD:6480464 |
CTD |
| G |
Col5a2 |
collagen, type V, alpha 2 |
|
decreases expression |
ISO |
9 |
44,374,113 |
44,525,086 |
RGD:6480464 |
CTD |
| G |
Cox6a2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
|
affects expression |
EXP |
1 |
187,464,579 |
187,465,301 |
RGD:6480464 |
CTD |
| G |
Cox6a2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
|
increases expression |
EXP |
1 |
187,464,579 |
187,465,301 |
RGD:6480464 |
CTD |
| G |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
|
affects expression |
ISO |
10 |
15,968,782 |
16,026,700 |
RGD:6480464 |
CTD |
| G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
|
increases response to substance |
ISO |
13 |
81,491,304 |
81,503,755 |
RGD:6480464 |
CTD |
| G |
Crem |
cAMP responsive element modulator |
|
decreases expression |
ISO |
17 |
62,770,633 |
62,837,670 |
RGD:6480464 |
CTD |
| G |
Crot |
carnitine O-octanoyltransferase |
|
increases methylation |
ISO |
4 |
22,023,913 |
22,067,029 |
RGD:6480464 |
CTD |
| G |
Crtc1 |
CREB regulated transcription coactivator 1 |
|
increases methylation |
ISO |
16 |
19,494,580 |
19,536,787 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
affects expression |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
|
decreases expression |
ISO |
5 |
145,374,596 |
145,394,045 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
increases expression |
ISO |
3 |
142,564,754 |
142,609,311 |
RGD:6480464 |
CTD |
| G |
Cst3 |
cystatin C |
|
increases expression |
EXP |
3 |
137,650,903 |
137,654,776 |
RGD:6480464 |
CTD |
| G |
Cth |
cystathionase (cystathionine gamma-lyase) |
|
decreases expression |
ISO |
2 |
256,056,562 |
256,082,248 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
increases expression |
EXP |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Cttnbp2nl |
CTTNBP2 N-terminal like |
|
decreases expression |
ISO |
2 |
200,272,402 |
200,319,448 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
decreases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
decreases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
decreases expression |
ISO |
14 |
18,767,306 |
18,787,340 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
multiple interactions |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
decreases expression |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cxcr5 |
chemokine (C-X-C motif) receptor 5 |
|
decreases expression |
ISO |
8 |
47,485,125 |
47,498,509 |
RGD:6480464 |
CTD |
| G |
Cxcr5 |
chemokine (C-X-C motif) receptor 5 |
|
multiple interactions |
ISO |
8 |
47,485,125 |
47,498,509 |
RGD:6480464 |
CTD |
| G |
Cxxc5 |
CXXC finger protein 5 |
|
increases methylation |
ISO |
18 |
28,484,230 |
28,487,485 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
affects response to substance |
ISO |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
decreases expression |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp20a1 |
cytochrome P450, family 20, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
9 |
58,907,503 |
58,973,287 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases expression |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Daam2 |
dishevelled associated activator of morphogenesis 2 |
|
increases methylation |
ISO |
9 |
6,714,308 |
6,756,580 |
RGD:6480464 |
CTD |
| G |
Dcaf7 |
DDB1 and CUL4 associated factor 7 |
|
affects expression |
ISO |
10 |
95,425,072 |
95,451,229 |
RGD:6480464 |
CTD |
| G |
Dcakd |
dephospho-CoA kinase domain containing |
|
increases methylation |
ISO |
10 |
92,165,555 |
92,187,843 |
RGD:6480464 |
CTD |
| G |
Ddb2 |
damage specific DNA binding protein 2 |
|
decreases expression |
ISO |
3 |
75,568,487 |
75,591,428 |
RGD:6480464 |
CTD |
| G |
Ddx26b |
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26B |
|
increases methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Defb1 |
defensin beta 1 |
|
decreases expression |
ISO |
16 |
74,980,054 |
74,995,445 |
RGD:6480464 |
CTD |
| G |
Dffa |
DNA fragmentation factor, alpha subunit |
|
multiple interactions |
ISO |
5 |
166,179,130 |
166,192,029 |
RGD:6480464 |
CTD |
| G |
Dffb |
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
|
multiple interactions |
ISO |
5 |
170,750,718 |
170,762,034 |
RGD:6480464 |
CTD |
| G |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
|
affects expression |
ISO |
5 |
163,341,856 |
163,375,604 |
RGD:6480464 |
CTD |
| G |
Diaph2 |
diaphanous homolog 2 (Drosophila) |
|
decreases expression |
ISO |
X |
116,641,770 |
117,258,314 |
RGD:6480464 |
CTD |
| G |
Diexf |
digestive organ expansion factor homolog (zebrafish) |
|
increases methylation |
ISO |
13 |
108,945,112 |
108,966,381 |
RGD:6480464 |
CTD |
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
multiple interactions |
EXP |
5 |
128,385,702 |
128,404,015 |
RGD:6480464 |
CTD |
| G |
Dirc2 |
disrupted in renal carcinoma 2 |
|
increases methylation |
ISO |
11 |
66,829,715 |
66,910,201 |
RGD:6480464 |
CTD |
| G |
Dmrta2 |
DMRT-like family A2 |
|
increases methylation |
ISO |
5 |
131,410,451 |
131,416,198 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
EXP |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
increases expression |
EXP |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
affects metabolic processing |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dpp7 |
dipeptidylpeptidase 7 |
|
increases expression |
EXP |
3 |
3,514,968 |
3,519,220 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp3 |
dual specificity phosphatase 3 |
|
increases methylation |
ISO |
10 |
91,031,206 |
91,044,858 |
RGD:6480464 |
CTD |
| G |
Dynll2 |
dynein light chain LC8-type 2 |
|
affects expression |
ISO |
10 |
76,263,883 |
76,271,908 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
decreases expression |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f3 |
E2F transcription factor 3 |
|
increases expression |
ISO |
17 |
41,079,346 |
41,145,568 |
RGD:6480464 |
CTD |
| G |
E2f5 |
E2F transcription factor 5 |
|
increases expression |
ISO |
2 |
88,346,236 |
88,361,733 |
RGD:6480464 |
CTD |
| G |
E2f7 |
E2F transcription factor 7 |
|
decreases expression |
ISO |
7 |
49,689,755 |
49,751,823 |
RGD:6480464 |
CTD |
| G |
E2f8 |
E2F transcription factor 8 |
|
decreases expression |
ISO |
1 |
98,640,381 |
98,694,764 |
RGD:6480464 |
CTD |
| G |
Edn2 |
endothelin 2 |
|
increases expression |
ISO |
5 |
140,742,686 |
140,747,580 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
increases expression |
ISO |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
affects expression |
ISO |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
decreases expression |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Eef1e1 |
eukaryotic translation elongation factor 1 epsilon 1 |
|
increases methylation |
ISO |
17 |
32,217,424 |
32,228,130 |
RGD:6480464 |
CTD |
| G |
Efcab2 |
EF-hand calcium binding domain 2 |
|
affects expression |
ISO |
13 |
94,052,873 |
94,138,884 |
RGD:6480464 |
CTD |
| G |
Efnb2 |
ephrin B2 |
|
decreases expression |
ISO |
16 |
86,187,639 |
86,228,023 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
|
affects expression |
ISO |
20 |
29,562,634 |
29,579,209 |
RGD:6480464 |
CTD |
| G |
Eif5a |
eukaryotic translation initiation factor 5A |
|
increases response to substance |
ISO |
10 |
56,760,289 |
56,764,689 |
RGD:6480464 |
CTD |
| G |
Emr1 |
EGF-like module containing, mucin-like, hormone receptor-like 1 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
|
affects expression |
ISO |
9 |
108,303,607 |
108,426,942 |
RGD:6480464 |
CTD |
| G |
Epm2aip1 |
EPM2A (laforin) interacting protein 1 |
|
decreases expression |
ISO |
8 |
115,653,794 |
115,656,867 |
RGD:6480464 |
CTD |
| G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
decreases expression |
ISO |
1 |
78,711,249 |
78,722,474 |
RGD:6480464 |
CTD |
| G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
decreases expression |
ISO |
1 |
78,711,249 |
78,722,474 |
RGD:6480464 |
CTD |
| G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
increases expression |
ISO |
1 |
78,711,249 |
78,722,474 |
RGD:6480464 |
CTD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ercc3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 |
|
decreases expression |
ISO |
18 |
24,684,912 |
24,716,143 |
RGD:6480464 |
CTD |
| G |
Ercc4 |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
|
decreases expression |
ISO |
10 |
2,144,262 |
2,177,554 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
increases expression |
ISO |
9 |
43,248,023 |
43,293,196 |
RGD:6480464 |
CTD |
| G |
Ercc6 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 |
|
affects expression |
ISO |
16 |
8,024,881 |
8,091,587 |
RGD:6480464 |
CTD |
| G |
Ermp1 |
endoplasmic reticulum metallopeptidase 1 |
|
affects expression |
ISO |
1 |
233,326,954 |
233,361,107 |
RGD:6480464 |
CTD |
| G |
Ern2 |
endoplasmic reticulum to nucleus signaling 2 |
|
affects expression |
ISO |
1 |
181,012,795 |
181,029,728 |
RGD:6480464 |
CTD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
decreases expression |
ISO |
5 |
168,012,683 |
168,025,963 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases methylation |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Exoc8 |
exocyst complex component 8 |
|
affects expression |
ISO |
19 |
55,066,272 |
55,068,761 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
affects expression |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
F5 |
coagulation factor V (proaccelerin, labile factor) |
|
decreases expression |
ISO |
13 |
79,934,956 |
79,997,285 |
RGD:6480464 |
CTD |
| G |
Fads2 |
fatty acid desaturase 2 |
|
decreases expression |
EXP |
1 |
212,512,691 |
212,542,622 |
RGD:6480464 |
CTD |
| G |
Fam105b |
family with sequence similarity 105, member B |
|
affects expression |
ISO |
2 |
79,431,094 |
79,454,752 |
RGD:6480464 |
CTD |
| G |
Fam107a |
family with sequence similarity 107, member A |
|
decreases expression |
ISO |
15 |
18,598,082 |
18,613,890 |
RGD:6480464 |
CTD |
| G |
Fam117b |
family with sequence similarity 117, member B |
|
affects expression |
ISO |
9 |
58,476,287 |
58,544,228 |
RGD:6480464 |
CTD |
| G |
Fam149b1 |
family with sequence similarity 149, member B1 |
|
increases methylation |
ISO |
15 |
4,157,828 |
4,196,419 |
RGD:6480464 |
CTD |
| G |
Fam53a |
family with sequence similarity 53, member A |
|
increases methylation |
ISO |
14 |
82,786,786 |
82,821,970 |
RGD:6480464 |
CTD |
| G |
Fam53c |
family with sequence similarity 53, member C |
|
affects expression |
ISO |
18 |
27,237,519 |
27,245,127 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fbxl5 |
F-box and leucine-rich repeat protein 5 |
|
affects expression |
ISO |
14 |
72,471,063 |
72,510,384 |
RGD:6480464 |
CTD |
| G |
Fbxo3 |
F-box protein 3 |
|
affects expression |
ISO |
3 |
89,446,724 |
89,479,650 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
affects expression |
ISO |
7 |
94,909,568 |
94,942,444 |
RGD:6480464 |
CTD |
| G |
Fcrl1 |
Fc receptor-like 1 |
|
affects expression |
ISO |
2 |
179,416,663 |
179,425,297 |
RGD:6480464 |
CTD |
| G |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
|
increases response to substance |
ISO |
8 |
38,078,328 |
38,123,983 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
decreases expression |
ISO |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
decreases expression |
ISO |
17 |
15,512,144 |
15,527,348 |
RGD:6480464 |
CTD |
| G |
Fkbp14 |
FK506 binding protein 14 |
|
decreases expression |
ISO |
4 |
82,985,646 |
83,000,392 |
RGD:6480464 |
CTD |
| G |
Fmo2 |
flavin containing monooxygenase 2 |
|
decreases expression |
ISO |
13 |
78,546,315 |
78,592,870 |
RGD:6480464 |
CTD |
| G |
Foxp1 |
forkhead box P1 |
|
increases methylation |
ISO |
4 |
133,773,373 |
134,007,018 |
RGD:6480464 |
CTD |
| G |
Fpr1 |
formyl peptide receptor 1 |
|
decreases expression |
ISO |
1 |
56,587,183 |
56,588,390 |
RGD:6480464 |
CTD |
| G |
Fpr2 |
formyl peptide receptor 2 |
|
decreases expression |
ISO |
1 |
56,622,816 |
56,624,057 |
RGD:6480464 |
CTD |
| G |
Fpr3 |
formyl peptide receptor 3 |
|
decreases expression |
ISO |
1 |
56,730,912 |
56,783,230 |
RGD:6480464 |
CTD |
| G |
Fus |
fused in sarcoma |
|
decreases expression |
ISO |
1 |
187,250,871 |
187,264,742 |
RGD:6480464 |
CTD |
| G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
|
affects expression |
ISO |
8 |
48,379,075 |
48,385,553 |
RGD:6480464 |
CTD |
| G |
Gabpb2 |
GA binding protein transcription factor, beta subunit 2 |
|
decreases expression |
ISO |
2 |
190,094,254 |
190,114,114 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
decreases expression |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Galnt10 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) |
|
affects expression |
ISO |
10 |
43,237,411 |
43,381,584 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
decreases expression |
ISO |
11 |
59,989,085 |
60,083,971 |
RGD:6480464 |
CTD |
| G |
Gbp5 |
guanylate binding protein 5 |
|
affects expression |
ISO |
2 |
240,428,472 |
240,447,791 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
increases methylation |
ISO |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gcn1l1 |
GCN1 general control of amino-acid synthesis 1-like 1 (yeast) |
|
affects expression |
ISO |
12 |
42,253,048 |
42,313,931 |
RGD:6480464 |
CTD |
| G |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
|
decreases expression |
ISO |
17 |
29,767,383 |
29,808,950 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
decreases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
decreases expression |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ggta1 |
glycoprotein, alpha-galactosyltransferase 1 |
|
decreases expression |
ISO |
3 |
14,485,028 |
14,559,484 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
decreases activity |
ISO |
9 |
46,380,165 |
46,452,974 |
RGD:6480464 |
CTD |
| G |
Gltp |
glycolipid transfer protein |
|
increases methylation |
ISO |
12 |
43,195,541 |
43,215,694 |
RGD:6480464 |
CTD |
| G |
Gltscr1l |
GLTSCR1-like |
|
increases methylation |
ISO |
9 |
9,349,439 |
9,379,804 |
RGD:6480464 |
CTD |
| G |
Gmps |
guanine monphosphate synthetase |
|
decreases expression |
ISO |
2 |
153,804,512 |
153,840,009 |
RGD:6480464 |
CTD |
| G |
Gna11 |
guanine nucleotide binding protein, alpha 11 |
|
increases methylation |
ISO |
7 |
9,636,748 |
9,662,492 |
RGD:6480464 |
CTD |
| G |
Golga4 |
golgin A4 |
|
decreases expression |
ISO |
8 |
123,404,540 |
123,504,104 |
RGD:6480464 |
CTD |
| G |
Golga4 |
golgin A4 |
|
decreases expression |
ISO |
8 |
123,404,540 |
123,504,104 |
RGD:6480464 |
CTD |
| G |
Gpnmb |
glycoprotein (transmembrane) nmb |
|
affects expression |
EXP |
4 |
77,161,352 |
77,182,624 |
RGD:6480464 |
CTD |
| G |
Gpnmb |
glycoprotein (transmembrane) nmb |
|
increases expression |
EXP |
4 |
77,161,352 |
77,182,624 |
RGD:6480464 |
CTD |
| G |
Gpr56 |
G protein-coupled receptor 56 |
|
affects expression |
ISO |
19 |
10,438,332 |
10,475,607 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Grpel1 |
GrpE-like 1, mitochondrial |
|
affects expression |
ISO |
14 |
79,873,191 |
79,878,998 |
RGD:6480464 |
CTD |
| G |
Gsc |
goosecoid homeobox |
|
increases methylation |
ISO |
6 |
128,526,645 |
128,528,684 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
increases expression |
ISO |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
multiple interactions |
ISO |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
decreases response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
multiple interactions |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects metabolic processing |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
increases expression |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
multiple interactions |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
multiple interactions |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
affects metabolic processing |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
decreases metabolic processing |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
increases metabolic processing |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gsto2 |
glutathione S-transferase omega 2 |
|
multiple interactions |
ISO |
1 |
253,239,392 |
253,275,110 |
RGD:6480464 |
CTD |
| G |
Gsto2 |
glutathione S-transferase omega 2 |
|
affects response to substance |
ISO |
1 |
253,239,392 |
253,275,110 |
RGD:6480464 |
CTD |
| G |
Gsto2 |
glutathione S-transferase omega 2 |
|
affects metabolic processing |
ISO |
1 |
253,239,392 |
253,275,110 |
RGD:6480464 |
CTD |
| G |
Gsto2 |
glutathione S-transferase omega 2 |
|
affects response to substance |
ISO |
1 |
253,239,392 |
253,275,110 |
RGD:6480464 |
CTD |
| G |
Gsto2 |
glutathione S-transferase omega 2 |
|
increases metabolic processing |
ISO |
1 |
253,239,392 |
253,275,110 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
affects response to substance |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects response to substance |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects response to substance |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gtpbp5 |
GTP binding protein 5 |
|
affects expression |
ISO |
3 |
169,129,431 |
169,144,778 |
RGD:6480464 |
CTD |
| G |
Gtse1 |
G-2 and S-phase expressed 1 |
|
increases methylation |
ISO |
7 |
123,862,066 |
123,878,554 |
RGD:6480464 |
CTD |
| G |
Gtse1 |
G-2 and S-phase expressed 1 |
|
increases expression |
ISO |
7 |
123,862,066 |
123,878,554 |
RGD:6480464 |
CTD |
| G |
Guca1b |
guanylate cyclase activator 1B |
|
affects expression |
ISO |
9 |
9,058,038 |
9,065,831 |
RGD:6480464 |
CTD |
| G |
Hapln2 |
hyaluronan and proteoglycan link protein 2 |
|
affects expression |
ISO |
2 |
180,104,684 |
180,110,113 |
RGD:6480464 |
CTD |
| G |
Hat1 |
histone acetyltransferase 1 |
|
increases methylation |
ISO |
3 |
53,696,664 |
53,744,333 |
RGD:6480464 |
CTD |
| G |
Haus3 |
HAUS augmin-like complex, subunit 3 |
|
affects expression |
ISO |
14 |
82,271,675 |
82,291,082 |
RGD:6480464 |
CTD |
| G |
Hdhd3 |
haloacid dehalogenase-like hydrolase domain containing 3 |
|
increases methylation |
ISO |
5 |
79,494,960 |
79,498,427 |
RGD:6480464 |
CTD |
| G |
Hecw2 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
|
decreases expression |
ISO |
9 |
52,623,951 |
52,839,918 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
increases expression |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hist3h3 |
histone cluster 3, H3 |
|
multiple interactions |
ISO |
10 |
45,252,993 |
45,253,403 |
RGD:6480464 |
CTD |
| G |
Hist3h3 |
histone cluster 3, H3 |
|
increases methylation |
ISO |
10 |
45,252,993 |
45,253,403 |
RGD:6480464 |
CTD |
| G |
Hmcn1 |
hemicentin 1 |
|
decreases expression |
ISO |
13 |
65,296,682 |
65,779,372 |
RGD:6480464 |
CTD |
| G |
Hmcn1 |
hemicentin 1 |
|
decreases expression |
ISO |
13 |
65,296,682 |
65,779,372 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
affects response to substance |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hoxb5 |
homeo box B5 |
|
increases methylation |
ISO |
10 |
85,035,516 |
85,037,724 |
RGD:6480464 |
CTD |
| G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
|
increases methylation |
ISO |
X |
41,489,343 |
41,491,788 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
decreases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
decreases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
decreases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ifi203-ps1 |
interferon activated gene 203, pseudogene 1 |
|
decreases expression |
ISO |
13 |
89,711,997 |
89,729,593 |
RGD:6480464 |
CTD |
| G |
Ifitm2 |
interferon induced transmembrane protein 2 |
|
decreases response to substance |
ISO |
1 |
201,134,357 |
201,135,537 |
RGD:6480464 |
CTD |
| G |
Ifitm6 |
interferon induced transmembrane protein 6 |
|
affects expression |
ISO |
1 |
201,204,645 |
201,205,945 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
increases response to substance |
ISO |
1 |
42,253,273 |
42,341,646 |
RGD:6480464 |
CTD |
| G |
Igsf6 |
immunoglobulin superfamily, member 6 |
|
affects expression |
ISO |
1 |
179,911,684 |
179,922,158 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
decreases expression |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
affects response to substance |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
affects response to substance |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10rb |
interleukin 10 receptor, beta |
|
decreases expression |
ISO |
11 |
31,381,317 |
31,397,079 |
RGD:6480464 |
CTD |
| G |
Il10rb |
interleukin 10 receptor, beta |
|
multiple interactions |
ISO |
11 |
31,381,317 |
31,397,079 |
RGD:6480464 |
CTD |
| G |
Il11 |
interleukin 11 |
|
multiple interactions |
ISO |
1 |
67,784,584 |
67,795,141 |
RGD:6480464 |
CTD |
| G |
Il11 |
interleukin 11 |
|
decreases expression |
ISO |
1 |
67,784,584 |
67,795,141 |
RGD:6480464 |
CTD |
| G |
Il13ra2 |
interleukin 13 receptor, alpha 2 |
|
decreases expression |
ISO |
X |
30,505,850 |
30,533,002 |
RGD:6480464 |
CTD |
| G |
Il13ra2 |
interleukin 13 receptor, alpha 2 |
|
multiple interactions |
ISO |
X |
30,505,850 |
30,533,002 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
multiple interactions |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il18r1 |
interleukin 18 receptor 1 |
|
multiple interactions |
ISO |
9 |
39,627,915 |
39,659,828 |
RGD:6480464 |
CTD |
| G |
Il18r1 |
interleukin 18 receptor 1 |
|
decreases expression |
ISO |
9 |
39,627,915 |
39,659,828 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
decreases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
increases expression |
ISO |
9 |
39,434,910 |
39,473,552 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
affects expression |
ISO |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
affects expression |
EXP |
9 |
39,577,879 |
39,624,781 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
decreases expression |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
decreases secretion |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
multiple interactions |
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:6480464 |
CTD |
| G |
Il2rb |
interleukin 2 receptor, beta |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Il36g |
interleukin 36, gamma |
|
decreases expression |
ISO |
3 |
2,432,285 |
2,438,437 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
increases expression |
ISO |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
decreases expression |
ISO |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Ing3 |
inhibitor of growth family, member 3 |
|
affects expression |
ISO |
4 |
48,255,445 |
48,281,131 |
RGD:6480464 |
CTD |
| G |
Irg1 |
immunoresponsive gene 1 |
|
decreases expression |
ISO |
15 |
87,056,688 |
87,066,471 |
RGD:6480464 |
CTD |
| G |
Isca1 |
iron-sulfur cluster assembly 1 homolog (S. cerevisiae) |
|
affects expression |
ISO |
17 |
10,808,966 |
10,821,681 |
RGD:6480464 |
CTD |
| G |
Isoc1 |
isochorismatase domain containing 1 |
|
decreases expression |
ISO |
18 |
54,471,690 |
54,492,099 |
RGD:6480464 |
CTD |
| G |
Itga7 |
integrin, alpha 7 |
|
affects expression |
ISO |
7 |
2,230,747 |
2,269,403 |
RGD:6480464 |
CTD |
| G |
Itga8 |
integrin, alpha 8 |
|
decreases expression |
ISO |
17 |
86,427,191 |
86,649,268 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
decreases expression |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
decreases expression |
ISO |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Jmjd6 |
jumonji domain containing 6 |
|
affects expression |
ISO |
10 |
106,942,942 |
106,948,652 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Kbtbd8 |
kelch repeat and BTB (POZ) domain containing 8 |
|
affects expression |
ISO |
4 |
129,486,938 |
129,498,495 |
RGD:6480464 |
CTD |
| G |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
|
increases methylation |
ISO |
3 |
92,781,795 |
92,784,921 |
RGD:6480464 |
CTD |
| G |
Kcne4 |
potassium voltage-gated channel, Isk-related family, member 4 |
|
decreases expression |
ISO |
9 |
78,200,904 |
78,202,092 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
affects expression |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Kcnj14 |
potassium inwardly-rectifying channel, subfamily J, member 14 |
|
increases methylation |
ISO |
1 |
96,293,795 |
96,297,747 |
RGD:6480464 |
CTD |
| G |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
|
decreases expression |
ISO |
10 |
100,574,985 |
100,576,268 |
RGD:6480464 |
CTD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
increases expression |
ISO |
8 |
20,259,178 |
20,266,351 |
RGD:6480464 |
CTD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
affects binding |
ISO |
8 |
20,259,178 |
20,266,351 |
RGD:6480464 |
CTD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
affects response to substance |
ISO |
8 |
20,259,178 |
20,266,351 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
decreases expression |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
decreases expression |
ISO |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Klc1 |
kinesin light chain 1 |
|
decreases expression |
ISO |
6 |
136,553,146 |
136,586,393 |
RGD:6480464 |
CTD |
| G |
Klf16 |
Kruppel-like factor 16 |
|
increases methylation |
ISO |
7 |
10,638,982 |
10,658,693 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
decreases expression |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klhl15 |
kelch-like family member 15 |
|
affects expression |
ISO |
X |
81,629,200 |
81,679,937 |
RGD:6480464 |
CTD |
| G |
Klhl32 |
kelch-like family member 32 |
|
increases methylation |
ISO |
5 |
39,657,167 |
39,903,042 |
RGD:6480464 |
CTD |
| G |
Klrk1 |
killer cell lectin-like receptor subfamily K, member 1 |
|
affects expression |
ISO |
4 |
166,914,786 |
166,922,659 |
RGD:6480464 |
CTD |
| G |
Kntc1 |
kinetochore associated 1 |
|
increases methylation |
ISO |
12 |
33,906,847 |
33,977,070 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
affects expression |
ISO |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Krr1 |
KRR1, small subunit (SSU) processome component, homolog (yeast) |
|
increases methylation |
ISO |
7 |
51,069,927 |
51,081,361 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
increases expression |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt27 |
keratin 27 |
|
increases methylation |
ISO |
10 |
88,248,561 |
88,253,844 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
decreases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt83 |
keratin 83 |
|
increases methylation |
ISO |
7 |
140,178,781 |
140,185,794 |
RGD:6480464 |
CTD |
| G |
Lamb1 |
laminin, beta 1 |
|
decreases expression |
ISO |
6 |
49,115,671 |
49,183,374 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
affects expression |
EXP |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
decreases expression |
EXP |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
decreases expression |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lig3 |
ligase III, DNA, ATP-dependent |
|
decreases expression |
ISO |
10 |
71,000,287 |
71,021,398 |
RGD:6480464 |
CTD |
| G |
Lig3 |
ligase III, DNA, ATP-dependent |
|
multiple interactions |
ISO |
10 |
71,000,287 |
71,021,398 |
RGD:6480464 |
CTD |
| G |
Lig4 |
ligase IV, DNA, ATP-dependent |
|
decreases expression |
ISO |
16 |
84,881,880 |
84,888,448 |
RGD:6480464 |
CTD |
| G |
Lig4 |
ligase IV, DNA, ATP-dependent |
|
multiple interactions |
ISO |
16 |
84,881,880 |
84,888,448 |
RGD:6480464 |
CTD |
| G |
Lipg |
lipase, endothelial |
|
decreases expression |
ISO |
18 |
71,795,150 |
71,816,056 |
RGD:6480464 |
CTD |
| G |
Lmf1 |
lipase maturation factor 1 |
|
affects expression |
ISO |
10 |
14,831,884 |
14,918,491 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
affects expression |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
LOC100362819 |
autism susceptibility candidate 2-like |
|
affects expression |
ISO |
12 |
26,069,494 |
26,166,764 |
RGD:6480464 |
CTD |
| G |
LOC498154 |
hypothetical protein LOC498154 |
|
affects expression |
ISO |
12 |
15,686,414 |
15,789,818 |
RGD:6480464 |
CTD |
| G |
LOC498750 |
similar to cDNA sequence BC005537 |
|
affects expression |
ISO |
17 |
47,318,994 |
47,346,617 |
RGD:6480464 |
CTD |
| G |
LOC502908 |
Ly49s8 |
|
decreases expression |
ISO |
4 |
168,575,548 |
168,597,527 |
RGD:6480464 |
CTD |
| G |
LOC654482 |
hypothetical protein LOC654482 |
|
increases methylation |
ISO |
8 |
4,863,693 |
4,881,270 |
RGD:6480464 |
CTD |
| G |
LOC681241 |
hypothetical protein LOC681241 |
|
affects expression |
ISO |
17 |
93,515,546 |
93,620,296 |
RGD:6480464 |
CTD |
| G |
Lphn3 |
latrophilin 3 |
|
decreases expression |
ISO |
14 |
28,385,112 |
28,854,677 |
RGD:6480464 |
CTD |
| G |
Lpin2 |
lipin 2 |
|
decreases expression |
ISO |
9 |
110,380,692 |
110,484,329 |
RGD:6480464 |
CTD |
| G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
|
affects expression |
ISO |
4 |
128,919,630 |
129,082,488 |
RGD:6480464 |
CTD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
multiple interactions |
ISO |
20 |
3,657,842 |
3,659,848 |
RGD:6480464 |
CTD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
decreases expression |
ISO |
20 |
3,657,842 |
3,659,848 |
RGD:6480464 |
CTD |
| G |
Ltb |
lymphotoxin beta (TNF superfamily, member 3) |
|
multiple interactions |
ISO |
20 |
3,666,524 |
3,668,369 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
increases expression |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Magix |
MAGI family member, X-linked |
|
increases methylation |
ISO |
X |
26,865,047 |
26,871,907 |
RGD:6480464 |
CTD |
| G |
Malt1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
increases expression |
ISO |
18 |
61,708,388 |
61,760,004 |
RGD:6480464 |
CTD |
| G |
Malt1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
affects expression |
ISO |
18 |
61,708,388 |
61,760,004 |
RGD:6480464 |
CTD |
| G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
|
decreases expression |
ISO |
5 |
151,873,619 |
151,885,483 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
affects expression |
ISO |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mastl |
microtubule associated serine/threonine kinase-like |
|
increases methylation |
ISO |
17 |
96,722,615 |
96,757,971 |
RGD:6480464 |
CTD |
| G |
Mat2a |
methionine adenosyltransferase II, alpha |
|
affects expression |
ISO |
4 |
105,739,943 |
105,745,472 |
RGD:6480464 |
CTD |
| G |
Mat2b |
methionine adenosyltransferase II, beta |
|
affects expression |
ISO |
10 |
25,713,132 |
25,718,879 |
RGD:6480464 |
CTD |
| G |
Matk |
megakaryocyte-associated tyrosine kinase |
|
affects expression |
ISO |
7 |
9,940,799 |
9,945,824 |
RGD:6480464 |
CTD |
| G |
Mbd1 |
methyl-CpG binding domain protein 1 |
|
decreases expression |
ISO |
18 |
71,068,257 |
71,082,734 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
decreases expression |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
affects expression |
ISO |
2 |
12,331,078 |
12,346,520 |
RGD:6480464 |
CTD |
| G |
Meis2 |
Meis homeobox 2 |
|
increases response to substance |
ISO |
3 |
101,915,966 |
102,117,215 |
RGD:6480464 |
CTD |
| G |
Mettl7a |
methyltransferase like 7A |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mlc1 |
megalencephalic leukoencephalopathy with subcortical cysts 1 |
|
affects expression |
ISO |
7 |
127,265,491 |
127,288,102 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp8 |
matrix metallopeptidase 8 |
|
affects expression |
ISO |
8 |
4,402,124 |
4,410,976 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmrn2 |
multimerin 2 |
|
increases methylation |
ISO |
16 |
10,031,365 |
10,052,169 |
RGD:6480464 |
CTD |
| G |
Mms19l |
MMS19-like (MET18 homolog, S. cerevisiae) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mon2 |
MON2 homolog (S. cerevisiae) |
|
increases methylation |
ISO |
7 |
62,763,964 |
62,840,578 |
RGD:6480464 |
CTD |
| G |
Mospd2 |
motile sperm domain containing 2 |
|
decreases expression |
ISO |
X |
50,160,231 |
50,202,085 |
RGD:6480464 |
CTD |
| G |
Mpi |
mannose phosphate isomerase (mapped) |
|
increases methylation |
ISO |
8 |
61,298,820 |
61,306,727 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
increases response to substance |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpp5 |
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) |
|
decreases expression |
ISO |
6 |
101,414,657 |
101,471,504 |
RGD:6480464 |
CTD |
| G |
Mrap |
melanocortin 2 receptor accessory protein |
|
increases expression |
ISO |
11 |
30,720,783 |
30,731,275 |
RGD:6480464 |
CTD |
| G |
Mras |
muscle RAS oncogene homolog |
|
affects expression |
ISO |
8 |
104,244,660 |
104,272,556 |
RGD:6480464 |
CTD |
| G |
Ms4a1 |
membrane-spanning 4-domains, subfamily A, member 1 |
|
decreases expression |
ISO |
1 |
213,763,696 |
213,770,756 |
RGD:6480464 |
CTD |
| G |
Ms4a6a |
membrane-spanning 4-domains, subfamily A, member 6A |
|
decreases expression |
ISO |
1 |
214,046,885 |
214,057,578 |
RGD:6480464 |
CTD |
| G |
Msi2 |
musashi RNA-binding protein 2 |
|
decreases expression |
ISO |
10 |
76,776,415 |
77,149,277 |
RGD:6480464 |
CTD |
| G |
Msx1 |
msh homeobox 1 |
|
increases methylation |
ISO |
14 |
78,257,345 |
78,261,144 |
RGD:6480464 |
CTD |
| G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
|
increases expression |
ISO |
MT |
7,006 |
7,689 |
RGD:6480464 |
CTD |
| G |
Mt-nd4 |
mitochondrially encoded NADH dehydrogenase 4 |
|
increases expression |
ISO |
MT |
10,160 |
11,537 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects binding |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
decreases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects response to substance |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
decreases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects response to substance |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
increases expression |
ISO |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
multiple interactions |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects metabolic processing |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects metabolic processing |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects methylation |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
affects metabolic processing |
ISO |
17 |
5,086,219 |
5,118,086 |
RGD:6480464 |
CTD |
| G |
Mup1 |
major urinary protein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mxd1 |
max dimerization protein 1 |
|
decreases expression |
ISO |
4 |
120,801,932 |
120,822,346 |
RGD:6480464 |
CTD |
| G |
Mxd3 |
Max dimerization protein 3 |
|
affects expression |
ISO |
17 |
15,346,165 |
15,349,891 |
RGD:6480464 |
CTD |
| G |
Myct1 |
myc target 1 |
|
decreases expression |
ISO |
1 |
36,314,335 |
36,325,608 |
RGD:6480464 |
CTD |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
decreases expression |
ISO |
8 |
124,299,729 |
124,303,798 |
RGD:6480464 |
CTD |
| G |
Myh10 |
myosin, heavy chain 10, non-muscle |
|
increases response to substance |
ISO |
10 |
55,445,288 |
55,576,096 |
RGD:6480464 |
CTD |
| G |
Myl9 |
myosin, light chain 9, regulatory |
|
decreases expression |
EXP |
3 |
147,190,252 |
147,193,865 |
RGD:6480464 |
CTD |
| G |
Mylip |
myosin regulatory light chain interacting protein |
|
decreases response to substance |
ISO |
17 |
25,308,147 |
25,329,887 |
RGD:6480464 |
CTD |
| G |
Myo1b |
myosin Ib |
|
decreases expression |
ISO |
9 |
46,756,678 |
46,917,169 |
RGD:6480464 |
CTD |
| G |
Myom2 |
myomesin 2 |
|
decreases expression |
ISO |
16 |
79,330,395 |
79,402,689 |
RGD:6480464 |
CTD |
| G |
Myrip |
myosin VIIA and Rab interacting protein |
|
decreases expression |
ISO |
8 |
125,317,671 |
125,478,667 |
RGD:6480464 |
CTD |
| G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
|
decreases expression |
ISO |
12 |
4,184,417 |
4,205,550 |
RGD:6480464 |
CTD |
| G |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
|
affects response to substance |
ISO |
11 |
27,107,106 |
27,119,552 |
RGD:6480464 |
CTD |
| G |
Narg2 |
NMDA receptor regulated 2 |
|
increases methylation |
ISO |
8 |
73,836,837 |
73,876,618 |
RGD:6480464 |
CTD |
| G |
Ncam1 |
neural cell adhesion molecule 1 |
|
affects expression |
ISO |
8 |
52,822,350 |
53,120,572 |
RGD:6480464 |
CTD |
| G |
Ncan |
neurocan |
|
increases methylation |
ISO |
16 |
19,785,175 |
19,811,651 |
RGD:6480464 |
CTD |
| G |
Ncbp2 |
nuclear cap binding protein subunit 2 |
|
increases methylation |
ISO |
11 |
70,642,907 |
70,651,744 |
RGD:6480464 |
CTD |
| G |
Nckap5 |
NCK-associated protein 5 |
|
decreases expression |
ISO |
13 |
38,444,115 |
39,275,959 |
RGD:6480464 |
CTD |
| G |
Ndufa4l2 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
|
increases methylation |
ISO |
7 |
67,492,198 |
67,494,324 |
RGD:6480464 |
CTD |
| G |
Ndufb8 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 |
|
decreases expression |
ISO |
1 |
249,597,402 |
249,602,443 |
RGD:6480464 |
CTD |
| G |
Ndufs2 |
NADH dehydrogenase (ubiquinone) Fe-S protein 2 |
|
increases methylation |
ISO |
13 |
87,124,431 |
87,137,497 |
RGD:6480464 |
CTD |
| G |
Ndufs3 |
NADH dehydrogenase (ubiquinone) Fe-S protein 3 |
|
increases expression |
ISO |
3 |
75,256,383 |
75,263,560 |
RGD:6480464 |
CTD |
| G |
Ndufv1 |
NADH dehydrogenase (ubiquinone) flavoprotein 1 |
|
increases methylation |
ISO |
1 |
206,590,023 |
206,595,056 |
RGD:6480464 |
CTD |
| G |
Nebl |
nebulette |
|
decreases expression |
ISO |
17 |
91,518,949 |
91,626,869 |
RGD:6480464 |
CTD |
| G |
Nefh |
neurofilament, heavy polypeptide |
|
affects expression |
ISO |
14 |
85,594,789 |
85,604,774 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
affects expression |
ISO |
15 |
47,636,303 |
47,640,176 |
RGD:6480464 |
CTD |
| G |
Nefm |
neurofilament, medium polypeptide |
|
affects expression |
ISO |
15 |
47,698,371 |
47,703,350 |
RGD:6480464 |
CTD |
| G |
Nfatc3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
affects expression |
ISO |
19 |
35,907,800 |
35,982,095 |
RGD:6480464 |
CTD |
| G |
Nfe2 |
nuclear factor, erythroid derived 2 |
|
decreases expression |
ISO |
7 |
142,157,045 |
142,164,122 |
RGD:6480464 |
CTD |
| G |
Nfe2l1 |
nuclear factor, erythroid derived 2,-like 1 |
|
increases expression |
ISO |
10 |
85,570,238 |
85,577,636 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases response to substance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases activity |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects binding |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects response to substance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
|
increases methylation |
ISO |
17 |
18,092,489 |
18,107,708 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbie |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
|
decreases response to substance |
ISO |
9 |
11,044,112 |
11,050,948 |
RGD:6480464 |
CTD |
| G |
Ngp |
neutrophilic granule protein |
|
affects expression |
ISO |
8 |
114,795,567 |
114,798,934 |
RGD:6480464 |
CTD |
| G |
Nhp2l1 |
NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) |
|
affects expression |
ISO |
7 |
120,425,064 |
120,430,031 |
RGD:6480464 |
CTD |
| G |
Nipsnap1 |
nipsnap homolog 1 (C. elegans) |
|
increases methylation |
ISO |
14 |
85,532,437 |
85,556,559 |
RGD:6480464 |
CTD |
| G |
Nkx2-6 |
NK2 homeobox 6 |
|
increases methylation |
ISO |
15 |
49,712,260 |
49,716,355 |
RGD:6480464 |
CTD |
| G |
Nmd3 |
NMD3 homolog (S. cerevisiae) |
|
affects expression |
ISO |
2 |
159,851,267 |
159,876,465 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
affects response to substance |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
decreases expression |
ISO |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Npr3 |
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
|
decreases expression |
ISO |
2 |
61,278,264 |
61,341,460 |
RGD:6480464 |
CTD |
| G |
Nptx1 |
neuronal pentraxin I |
|
decreases expression |
ISO |
10 |
108,918,661 |
108,927,616 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases activity |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
increases methylation |
ISO |
1 |
95,027,197 |
95,032,516 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
decreases expression |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
decreases expression |
ISO |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
decreases expression |
ISO |
3 |
38,866,205 |
38,871,678 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
decreases expression |
ISO |
3 |
38,866,205 |
38,871,678 |
RGD:6480464 |
CTD |
| G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
|
decreases expression |
ISO |
5 |
64,713,468 |
64,753,311 |
RGD:6480464 |
CTD |
| G |
Nras |
neuroblastoma ras oncogene |
|
increases expression |
ISO |
2 |
198,292,650 |
198,300,286 |
RGD:6480464 |
CTD |
| G |
Nrbp2 |
nuclear receptor binding protein 2 |
|
increases methylation |
ISO |
7 |
114,117,884 |
114,123,617 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
increases expression |
ISO |
4 |
56,949,553 |
57,048,149 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
increases expression |
ISO |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nrip3 |
nuclear receptor interacting protein 3 |
|
affects expression |
ISO |
1 |
167,380,328 |
167,405,899 |
RGD:6480464 |
CTD |
| G |
Nrn1 |
neuritin 1 |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ntmt1 |
N-terminal Xaa-Pro-Lys N-methyltransferase 1 |
|
affects expression |
ISO |
3 |
9,860,524 |
9,877,109 |
RGD:6480464 |
CTD |
| G |
Ntn4 |
netrin 4 |
|
decreases expression |
ISO |
7 |
30,717,988 |
30,832,378 |
RGD:6480464 |
CTD |
| G |
Nuak2 |
NUAK family, SNF1-like kinase, 2 |
|
affects expression |
ISO |
13 |
45,205,573 |
45,222,322 |
RGD:6480464 |
CTD |
| G |
Nudt4 |
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
|
increases expression |
EXP |
7 |
32,753,728 |
32,769,953 |
RGD:6480464 |
CTD |
| G |
Numb |
numb homolog (Drosophila) |
|
decreases expression |
ISO |
6 |
107,838,216 |
107,882,302 |
RGD:6480464 |
CTD |
| G |
Nup160 |
nucleoporin 160 |
|
increases response to substance |
ISO |
3 |
75,041,873 |
75,102,540 |
RGD:6480464 |
CTD |
| G |
Nup210 |
nucleoporin 210 |
|
affects expression |
ISO |
4 |
125,189,612 |
125,285,493 |
RGD:6480464 |
CTD |
| G |
Nup62cl |
nucleoporin 62 C-terminal like |
|
increases methylation |
ISO |
X |
127,752,322 |
127,812,950 |
RGD:6480464 |
CTD |
| G |
Nupl1 |
nucleoporin like 1 |
|
affects expression |
ISO |
15 |
39,317,826 |
39,350,075 |
RGD:6480464 |
CTD |
| G |
Oasl |
2'-5'-oligoadenylate synthetase-like |
|
increases methylation |
ISO |
12 |
42,956,466 |
42,969,826 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
increases expression |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
affects expression |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
decreases expression |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
increases expression |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
multiple interactions |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
increases expression |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
multiple interactions |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Osbpl5 |
oxysterol binding protein-like 5 |
|
affects expression |
ISO |
1 |
204,065,865 |
204,120,445 |
RGD:6480464 |
CTD |
| G |
Osm |
oncostatin M |
|
increases expression |
ISO |
14 |
84,857,232 |
84,860,082 |
RGD:6480464 |
CTD |
| G |
Osmr |
oncostatin M receptor |
|
decreases expression |
ISO |
2 |
56,080,700 |
56,121,463 |
RGD:6480464 |
CTD |
| G |
Osr1 |
odd-skipped related 1 (Drosophila) |
|
increases methylation |
ISO |
6 |
33,074,410 |
33,076,769 |
RGD:6480464 |
CTD |
| G |
P2ry12 |
purinergic receptor P2Y, G-protein coupled, 12 |
|
decreases expression |
ISO |
2 |
148,611,035 |
148,613,985 |
RGD:6480464 |
CTD |
| G |
P4ha1 |
prolyl 4-hydroxylase, alpha polypeptide I |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Palm |
paralemmin |
|
increases methylation |
ISO |
7 |
11,399,529 |
11,425,964 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
decreases expression |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp10 |
poly (ADP-ribose) polymerase family, member 10 |
|
affects expression |
ISO |
7 |
114,264,013 |
114,273,086 |
RGD:6480464 |
CTD |
| G |
Parp4 |
poly (ADP-ribose) polymerase family, member 4 |
|
decreases expression |
ISO |
15 |
35,564,314 |
35,659,367 |
RGD:6480464 |
CTD |
| G |
Patl1 |
protein associated with topoisomerase II homolog 1 (yeast) |
|
increases methylation |
ISO |
1 |
214,755,170 |
214,787,272 |
RGD:6480464 |
CTD |
| G |
Pcdh17 |
protocadherin 17 |
|
decreases expression |
ISO |
15 |
66,391,901 |
66,482,530 |
RGD:6480464 |
CTD |
| G |
Pcdhga12 |
protocadherin gamma subfamily A, 12 |
|
increases methylation |
ISO |
18 |
30,673,815 |
30,754,205 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
decreases expression |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
|
increases expression |
ISO |
1 |
78,235,474 |
78,240,665 |
RGD:6480464 |
CTD |
| G |
Phf20 |
PHD finger protein 20 |
|
increases methylation |
ISO |
3 |
146,601,763 |
146,707,185 |
RGD:6480464 |
CTD |
| G |
Pi4k2b |
phosphatidylinositol 4-kinase type 2 beta |
|
decreases expression |
ISO |
14 |
62,975,861 |
63,002,714 |
RGD:6480464 |
CTD |
| G |
Pias1 |
protein inhibitor of activated STAT, 1 |
|
decreases expression |
ISO |
8 |
67,025,248 |
67,123,016 |
RGD:6480464 |
CTD |
| G |
Pigz |
phosphatidylinositol glycan anchor biosynthesis, class Z |
|
increases methylation |
ISO |
11 |
70,653,993 |
70,673,626 |
RGD:6480464 |
CTD |
| G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
increases expression |
ISO |
5 |
166,735,274 |
166,761,189 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
decreases expression |
ISO |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pik3r3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
|
increases response to substance |
ISO |
5 |
136,497,494 |
136,566,473 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
affects binding |
ISO |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Pla2g5 |
phospholipase A2, group V |
|
affects expression |
ISO |
5 |
157,619,703 |
157,640,971 |
RGD:6480464 |
CTD |
| G |
Plac9 |
placenta-specific 9 |
|
affects expression |
ISO |
16 |
1,497,710 |
1,512,542 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
decreases expression |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
decreases expression |
ISO |
3 |
122,797,718 |
123,523,675 |
RGD:6480464 |
CTD |
| G |
Plek |
pleckstrin |
|
decreases expression |
ISO |
14 |
97,841,595 |
97,875,052 |
RGD:6480464 |
CTD |
| G |
Plekha8 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8 |
|
increases methylation |
ISO |
4 |
83,003,032 |
83,049,649 |
RGD:6480464 |
CTD |
| G |
Plekhf1 |
pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
|
affects expression |
ISO |
1 |
90,697,260 |
90,698,737 |
RGD:6480464 |
CTD |
| G |
Plekhg3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
|
affects expression |
ISO |
6 |
99,157,196 |
99,175,135 |
RGD:6480464 |
CTD |
| G |
Plp1 |
proteolipid protein 1 |
|
decreases expression |
ISO |
X |
124,488,627 |
124,503,639 |
RGD:6480464 |
CTD |
| G |
Pls3 |
plastin 3 |
|
increases response to substance |
ISO |
X |
29,868,937 |
29,965,118 |
RGD:6480464 |
CTD |
| G |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
|
increases methylation |
ISO |
3 |
164,094,654 |
164,140,142 |
RGD:6480464 |
CTD |
| G |
Pml |
promyelocytic leukemia |
|
multiple interactions |
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:6480464 |
CTD |
| G |
Pml |
promyelocytic leukemia |
|
increases degradation |
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:6480464 |
CTD |
| G |
Pnp |
purine nucleoside phosphorylase |
|
multiple interactions |
ISO |
15 |
26,929,784 |
26,937,434 |
RGD:6480464 |
CTD |
| G |
Pnp |
purine nucleoside phosphorylase |
|
affects response to substance |
ISO |
15 |
26,929,784 |
26,937,434 |
RGD:6480464 |
CTD |
| G |
Pnp |
purine nucleoside phosphorylase |
|
increases response to substance |
ISO |
15 |
26,929,784 |
26,937,434 |
RGD:6480464 |
CTD |
| G |
Pnp |
purine nucleoside phosphorylase |
|
increases reduction |
ISO |
15 |
26,929,784 |
26,937,434 |
RGD:6480464 |
CTD |
| G |
Podxl |
podocalyxin-like |
|
decreases expression |
ISO |
4 |
58,611,904 |
58,658,598 |
RGD:6480464 |
CTD |
| G |
Polb |
polymerase (DNA directed), beta |
|
decreases expression |
ISO |
16 |
73,864,702 |
73,888,011 |
RGD:6480464 |
CTD |
| G |
Polb |
polymerase (DNA directed), beta |
|
multiple interactions |
ISO |
16 |
73,864,702 |
73,888,011 |
RGD:6480464 |
CTD |
| G |
Pold4 |
polymerase (DNA-directed), delta 4, accessory subunit |
|
increases methylation |
ISO |
1 |
206,815,462 |
206,817,131 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
affects response to substance |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
affects response to substance |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon2 |
paraoxonase 2 |
|
affects response to substance |
ISO |
4 |
30,033,229 |
30,068,643 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
affects expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
|
increases methylation |
ISO |
14 |
33,509,364 |
33,543,743 |
RGD:6480464 |
CTD |
| G |
Ppbp |
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
|
decreases expression |
ISO |
14 |
18,816,434 |
18,817,238 |
RGD:6480464 |
CTD |
| G |
Ppp2r1a |
protein phosphatase 2, regulatory subunit A, alpha |
|
affects expression |
ISO |
1 |
58,442,220 |
58,461,462 |
RGD:6480464 |
CTD |
| G |
Prdm2 |
PR domain containing 2, with ZNF domain |
|
increases methylation |
ISO |
5 |
161,962,929 |
162,072,519 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
increases expression |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
affects metabolic processing |
ISO |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
increases expression |
ISO |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Prf1 |
perforin 1 (pore forming protein) |
|
affects expression |
ISO |
20 |
28,658,367 |
28,663,877 |
RGD:6480464 |
CTD |
| G |
Prkar2a |
protein kinase, cAMP dependent regulatory, type II alpha |
|
decreases expression |
ISO |
8 |
113,746,384 |
113,805,476 |
RGD:6480464 |
CTD |
| G |
Prkd2 |
protein kinase D2 |
|
affects expression |
ISO |
1 |
77,168,290 |
77,197,277 |
RGD:6480464 |
CTD |
| G |
Prkd3 |
protein kinase D3 |
|
increases response to substance |
ISO |
6 |
1,727,315 |
1,796,290 |
RGD:6480464 |
CTD |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
decreases expression |
ISO |
11 |
86,951,420 |
87,169,229 |
RGD:6480464 |
CTD |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
multiple interactions |
ISO |
11 |
86,951,420 |
87,169,229 |
RGD:6480464 |
CTD |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
increases response to substance |
ISO |
11 |
86,951,420 |
87,169,229 |
RGD:6480464 |
CTD |
| G |
Prps1 |
phosphoribosyl pyrophosphate synthetase 1 |
|
increases methylation |
ISO |
X |
128,249,843 |
128,271,893 |
RGD:6480464 |
CTD |
| G |
Psmc6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
increases methylation |
ISO |
15 |
21,217,367 |
21,239,320 |
RGD:6480464 |
CTD |
| G |
Psmd14 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
|
affects expression |
ISO |
3 |
43,660,136 |
43,699,412 |
RGD:6480464 |
CTD |
| G |
Ptbp1 |
polypyrimidine tract binding protein 1 |
|
increases methylation |
ISO |
7 |
11,355,538 |
11,365,188 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
increases phosphorylation |
ISO |
7 |
110,933,298 |
111,084,554 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
decreases phosphorylation |
EXP |
7 |
110,933,298 |
111,084,554 |
RGD:6480464 |
CTD |
| G |
Ptpn9 |
protein tyrosine phosphatase, non-receptor type 9 |
|
increases methylation |
ISO |
8 |
60,737,741 |
60,817,948 |
RGD:6480464 |
CTD |
| G |
Ptx3 |
pentraxin 3, long |
|
affects expression |
ISO |
2 |
156,089,917 |
156,095,726 |
RGD:6480464 |
CTD |
| G |
Ptx3 |
pentraxin 3, long |
|
decreases expression |
ISO |
2 |
156,089,917 |
156,095,726 |
RGD:6480464 |
CTD |
| G |
PVR |
poliovirus receptor |
|
decreases expression |
ISO |
1 |
79,213,654 |
79,229,063 |
RGD:6480464 |
CTD |
| G |
Qprt |
quinolinate phosphoribosyltransferase |
|
decreases response to substance |
ISO |
1 |
186,358,523 |
186,374,681 |
RGD:6480464 |
CTD |
| G |
Rab31 |
RAB31, member RAS oncogene family |
|
decreases response to substance |
ISO |
9 |
104,408,546 |
104,543,084 |
RGD:6480464 |
CTD |
| G |
Rac2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
|
affects expression |
ISO |
7 |
116,520,066 |
116,532,482 |
RGD:6480464 |
CTD |
| G |
Rad18 |
RAD18 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
148,452,664 |
148,543,743 |
RGD:6480464 |
CTD |
| G |
Rad23a |
RAD23 homolog A (S. cerevisiae) |
|
increases expression |
ISO |
19 |
24,971,070 |
24,976,901 |
RGD:6480464 |
CTD |
| G |
Rai14 |
retinoic acid induced 14 |
|
decreases expression |
ISO |
2 |
59,923,115 |
60,060,724 |
RGD:6480464 |
CTD |
| G |
Ramp1 |
receptor (G protein-coupled) activity modifying protein 1 |
|
decreases expression |
EXP |
9 |
90,402,493 |
90,450,038 |
RGD:6480464 |
CTD |
| G |
Ranbp2 |
RAN binding protein 2 |
|
increases response to substance |
ISO |
20 |
37,271,467 |
37,322,723 |
RGD:6480464 |
CTD |
| G |
Ranbp6 |
RAN binding protein 6 |
|
affects expression |
ISO |
1 |
233,518,476 |
233,522,997 |
RGD:6480464 |
CTD |
| G |
Rasa1 |
RAS p21 protein activator (GTPase activating protein) 1 |
|
increases methylation |
ISO |
2 |
14,203,815 |
14,287,824 |
RGD:6480464 |
CTD |
| G |
Rasal2 |
RAS protein activator like 2 |
|
affects expression |
ISO |
13 |
72,381,047 |
72,534,202 |
RGD:6480464 |
CTD |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
increases methylation |
ISO |
8 |
112,798,863 |
112,810,004 |
RGD:6480464 |
CTD |
| G |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
|
affects expression |
ISO |
3 |
42,438,537 |
42,663,729 |
RGD:6480464 |
CTD |
| G |
Rbpjl2 |
recombination signal binding protein for immunoglobulin kappa J region-like 2 |
|
increases methylation |
ISO |
5 |
4,663,833 |
4,665,775 |
RGD:6480464 |
CTD |
| G |
Reg3a |
regenerating islet-derived 3 alpha |
|
increases expression |
ISO |
4 |
112,366,001 |
112,368,767 |
RGD:6480464 |
CTD |
| G |
Rfc2 |
replication factor C (activator 1) 2 |
|
increases expression |
ISO |
12 |
23,185,550 |
23,198,655 |
RGD:6480464 |
CTD |
| G |
Rgcc |
regulator of cell cycle |
|
affects expression |
ISO |
15 |
60,451,831 |
60,452,229 |
RGD:6480464 |
CTD |
| G |
RGD1311933 |
similar to RIKEN cDNA 2310057J18 |
|
increases methylation |
ISO |
1 |
29,599,530 |
29,615,619 |
RGD:6480464 |
CTD |
| G |
RGD1359529 |
similar to chromosome 1 open reading frame 63 |
|
decreases expression |
ISO |
5 |
153,698,946 |
153,702,685 |
RGD:6480464 |
CTD |
| G |
RGD1564887 |
similar to 9130011E15Rik protein |
|
affects expression |
ISO |
1 |
251,033,778 |
251,221,696 |
RGD:6480464 |
CTD |
| G |
Rgs1 |
regulator of G-protein signaling 1 |
|
decreases response to substance |
ISO |
13 |
58,121,188 |
58,125,514 |
RGD:6480464 |
CTD |
| G |
Rgs1 |
regulator of G-protein signaling 1 |
|
affects expression |
ISO |
13 |
58,121,188 |
58,125,514 |
RGD:6480464 |
CTD |
| G |
Rgs1 |
regulator of G-protein signaling 1 |
|
decreases expression |
ISO |
13 |
58,121,188 |
58,125,514 |
RGD:6480464 |
CTD |
| G |
Rgs18 |
regulator of G-protein signaling 18 |
|
decreases expression |
ISO |
13 |
58,607,898 |
58,629,597 |
RGD:6480464 |
CTD |
| G |
Rgs9 |
regulator of G-protein signaling 9 |
|
increases methylation |
ISO |
10 |
98,598,326 |
98,647,948 |
RGD:6480464 |
CTD |
| G |
Rhbdf1 |
rhomboid 5 homolog 1 (Drosophila) |
|
increases methylation |
ISO |
10 |
15,653,948 |
15,666,851 |
RGD:6480464 |
CTD |
| G |
Rhebl1 |
Ras homolog enriched in brain like 1 |
|
affects expression |
ISO |
7 |
137,645,541 |
137,649,476 |
RGD:6480464 |
CTD |
| G |
Rhobtb3 |
Rho-related BTB domain containing 3 |
|
increases response to substance |
ISO |
2 |
2,911,820 |
2,967,473 |
RGD:6480464 |
CTD |
| G |
Rhoq |
ras homolog family member Q |
|
increases methylation |
ISO |
6 |
10,414,042 |
10,449,472 |
RGD:6480464 |
CTD |
| G |
Riiad1 |
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 |
|
increases methylation |
ISO |
2 |
189,437,146 |
189,445,102 |
RGD:6480464 |
CTD |
| G |
Rimklb |
ribosomal modification protein rimK-like family member B |
|
affects expression |
ISO |
4 |
158,904,485 |
158,950,642 |
RGD:6480464 |
CTD |
| G |
Rnf13 |
ring finger protein 13 |
|
affects expression |
ISO |
2 |
146,995,576 |
147,061,229 |
RGD:6480464 |
CTD |
| G |
Rnf149 |
ring finger protein 149 |
|
increases expression |
ISO |
9 |
38,623,812 |
38,647,344 |
RGD:6480464 |
CTD |
| G |
Rnf20 |
ring finger protein 20, E3 ubiquitin protein ligase |
|
increases methylation |
ISO |
5 |
66,371,470 |
66,397,538 |
RGD:6480464 |
CTD |
| G |
Rnf216 |
ring finger protein 216 |
|
affects expression |
ISO |
12 |
11,850,549 |
11,968,127 |
RGD:6480464 |
CTD |
| G |
Rnf4 |
ring finger protein 4 |
|
multiple interactions |
ISO |
14 |
82,092,024 |
82,112,036 |
RGD:6480464 |
CTD |
| G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
|
increases response to substance |
ISO |
6 |
40,581,247 |
40,672,854 |
RGD:6480464 |
CTD |
| G |
Rp2 |
retinitis pigmentosa 2 homolog (human) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpp25 |
ribonuclease P/MRP 25 subunit |
|
affects expression |
ISO |
8 |
61,248,740 |
61,250,120 |
RGD:6480464 |
CTD |
| G |
Rrm2b |
ribonucleotide reductase M2 B (TP53 inducible) |
|
decreases expression |
ISO |
7 |
73,432,161 |
73,459,541 |
RGD:6480464 |
CTD |
| G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
|
decreases expression |
ISO |
6 |
44,100,775 |
44,113,910 |
RGD:6480464 |
CTD |
| G |
RT1-Ba |
RT1 class II, locus Ba |
|
affects expression |
ISO |
20 |
4,697,971 |
4,702,564 |
RGD:6480464 |
CTD |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
affects expression |
ISO |
20 |
4,730,559 |
4,736,201 |
RGD:6480464 |
CTD |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
decreases response to substance |
ISO |
20 |
4,730,559 |
4,736,201 |
RGD:6480464 |
CTD |
| G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
affects expression |
ISO |
20 |
4,671,489 |
4,681,058 |
RGD:6480464 |
CTD |
| G |
RT1-DMa |
RT1 class II, locus DMa |
|
decreases response to substance |
ISO |
20 |
4,843,458 |
4,846,861 |
RGD:6480464 |
CTD |
| G |
RT1-DOb |
RT1 class II, locus DOb |
|
decreases expression |
ISO |
20 |
4,753,940 |
4,759,648 |
RGD:6480464 |
CTD |
| G |
RT1-Ha |
RT1 class II, locus Ha |
|
affects expression |
ISO |
20 |
4,902,458 |
4,907,767 |
RGD:6480464 |
CTD |
| G |
Rufy3 |
RUN and FYVE domain containing 3 |
|
decreases expression |
ISO |
14 |
21,022,765 |
21,070,152 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
decreases expression |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
decreases expression |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
increases methylation |
ISO |
2 |
211,851,304 |
211,855,511 |
RGD:6480464 |
CTD |
| G |
S1pr4 |
sphingosine-1-phosphate receptor 4 |
|
affects expression |
ISO |
7 |
9,691,709 |
9,693,985 |
RGD:6480464 |
CTD |
| G |
S1pr5 |
sphingosine-1-phosphate receptor 5 |
|
increases methylation |
ISO |
8 |
20,278,404 |
20,283,375 |
RGD:6480464 |
CTD |
| G |
Sardh |
sarcosine dehydrogenase |
|
affects expression |
ISO |
3 |
6,076,166 |
6,142,565 |
RGD:6480464 |
CTD |
| G |
Sbf1 |
SET binding factor 1 |
|
affects expression |
ISO |
7 |
127,583,779 |
127,611,043 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
decreases expression |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scel |
sciellin |
|
decreases expression |
ISO |
15 |
87,547,770 |
87,678,387 |
RGD:6480464 |
CTD |
| G |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Scn3b |
sodium channel, voltage-gated, type III, beta |
|
decreases expression |
ISO |
8 |
43,231,453 |
43,254,066 |
RGD:6480464 |
CTD |
| G |
Scn7a |
sodium channel, voltage-gated, type VII, alpha |
|
decreases expression |
ISO |
3 |
48,633,302 |
48,710,734 |
RGD:6480464 |
CTD |
| G |
Sde2 |
SDE2 telomere maintenance homolog (S. pombe) |
|
affects expression |
ISO |
13 |
96,585,245 |
96,601,482 |
RGD:6480464 |
CTD |
| G |
Sdha |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
|
increases expression |
ISO |
1 |
29,739,359 |
29,764,329 |
RGD:6480464 |
CTD |
| G |
Selm |
selenoprotein M |
|
increases methylation |
ISO |
14 |
84,157,831 |
84,160,413 |
RGD:6480464 |
CTD |
| G |
Sema3c |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
|
decreases expression |
ISO |
4 |
13,739,659 |
13,914,636 |
RGD:6480464 |
CTD |
| G |
Sept9 |
septin 9 |
|
affects expression |
ISO |
10 |
107,343,672 |
107,479,964 |
RGD:6480464 |
CTD |
| G |
Serinc3 |
serine incorporator 3 |
|
decreases expression |
ISO |
3 |
154,539,792 |
154,559,239 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
|
increases expression |
ISO |
13 |
13,037,587 |
13,057,785 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
decreases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Sfn |
stratifin |
|
increases expression |
ISO |
5 |
151,475,395 |
151,479,996 |
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine-rich |
|
decreases expression |
ISO |
5 |
146,460,306 |
146,469,289 |
RGD:6480464 |
CTD |
| G |
Sgms1 |
sphingomyelin synthase 1 |
|
decreases expression |
ISO |
1 |
236,133,441 |
236,396,631 |
RGD:6480464 |
CTD |
| G |
Sh2d1b |
SH2 domain containing 1B |
|
affects expression |
ISO |
13 |
86,096,465 |
86,126,881 |
RGD:6480464 |
CTD |
| G |
Sidt2 |
SID1 transmembrane family, member 2 |
|
affects expression |
ISO |
8 |
48,909,652 |
48,925,969 |
RGD:6480464 |
CTD |
| G |
Skil |
SKI-like oncogene |
|
decreases expression |
ISO |
2 |
116,669,375 |
116,691,472 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
affects expression |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc13a4 |
solute carrier family 13 (sodium/sulfate symporters), member 4 |
|
multiple interactions |
EXP |
4 |
62,679,593 |
62,724,547 |
RGD:6480464 |
CTD |
| G |
Slc44a2 |
solute carrier family 44, member 2 |
|
affects expression |
ISO |
8 |
20,433,914 |
20,451,580 |
RGD:6480464 |
CTD |
| G |
Slc6a14 |
solute carrier family 6 (amino acid transporter), member 14 |
|
decreases expression |
ISO |
X |
12,048,993 |
12,072,434 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
decreases expression |
ISO |
19 |
15,098,281 |
15,139,898 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
increases expression |
EXP |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
affects expression |
ISO |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Slc9a3r1 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
|
affects expression |
ISO |
10 |
105,237,637 |
105,254,750 |
RGD:6480464 |
CTD |
| G |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
|
decreases expression |
ISO |
8 |
108,012,829 |
108,098,561 |
RGD:6480464 |
CTD |
| G |
Smarcc1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
|
affects expression |
ISO |
8 |
114,484,491 |
114,609,850 |
RGD:6480464 |
CTD |
| G |
Smarcd2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
|
increases methylation |
ISO |
10 |
95,656,976 |
95,665,842 |
RGD:6480464 |
CTD |
| G |
Smpdl3a |
sphingomyelin phosphodiesterase, acid-like 3A |
|
increases methylation |
ISO |
20 |
36,821,916 |
36,844,891 |
RGD:6480464 |
CTD |
| G |
Smpx |
small muscle protein, X-linked |
|
decreases expression |
ISO |
X |
58,521,059 |
58,581,070 |
RGD:6480464 |
CTD |
| G |
Snai3 |
snail homolog 3 (Drosophila) |
|
increases methylation |
ISO |
19 |
52,742,687 |
52,749,406 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
increases expression |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
affects expression |
ISO |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
affects response to substance |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
affects expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
|
increases methylation |
ISO |
1 |
245,419,532 |
245,527,846 |
RGD:6480464 |
CTD |
| G |
Sorl1 |
sortilin-related receptor, LDLR class A repeats-containing |
|
affects expression |
ISO |
8 |
44,962,730 |
45,101,843 |
RGD:6480464 |
CTD |
| G |
Sos1 |
Son of sevenless homolog 1 (Drosophila) |
|
affects expression |
ISO |
6 |
3,308,778 |
3,390,661 |
RGD:6480464 |
CTD |
| G |
Sos2 |
son of sevenless homolog 2 (Drosophila) |
|
increases methylation |
ISO |
6 |
91,609,463 |
91,722,481 |
RGD:6480464 |
CTD |
| G |
Sox11 |
SRY (sex determining region Y)-box 11 |
|
decreases expression |
ISO |
6 |
45,141,366 |
45,143,387 |
RGD:6480464 |
CTD |
| G |
Sox18 |
SRY (sex determining region Y)-box 18 |
|
decreases expression |
ISO |
3 |
170,820,460 |
170,822,262 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
decreases response to substance |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Spib |
Spi-B transcription factor (Spi-1/PU.1 related) |
|
decreases response to substance |
ISO |
1 |
95,004,163 |
95,009,998 |
RGD:6480464 |
CTD |
| G |
Sprn |
shadow of prion protein homolog (zebrafish) |
|
affects expression |
ISO |
1 |
199,953,310 |
199,953,753 |
RGD:6480464 |
CTD |
| G |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
|
affects expression |
ISO |
5 |
167,014,271 |
167,025,579 |
RGD:6480464 |
CTD |
| G |
Sptbn2 |
spectrin, beta, non-erythrocytic 2 |
|
increases methylation |
ISO |
1 |
207,318,258 |
207,358,896 |
RGD:6480464 |
CTD |
| G |
Srp68 |
signal recognition particle 68 |
|
decreases expression |
ISO |
10 |
106,359,742 |
106,387,284 |
RGD:6480464 |
CTD |
| G |
Srsf5 |
serine/arginine-rich splicing factor 5 |
|
increases expression |
ISO |
6 |
104,728,286 |
104,732,982 |
RGD:6480464 |
CTD |
| G |
Ssbp1 |
single-stranded DNA binding protein 1, mitochondrial |
|
decreases expression |
ISO |
4 |
68,027,304 |
68,036,581 |
RGD:6480464 |
CTD |
| G |
Ssh1 |
slingshot protein phosphatase 1 |
|
affects expression |
ISO |
12 |
43,660,409 |
43,714,743 |
RGD:6480464 |
CTD |
| G |
Ssrp1 |
structure specific recognition protein 1 |
|
affects expression |
ISO |
3 |
68,272,947 |
68,282,596 |
RGD:6480464 |
CTD |
| G |
Sstr4 |
somatostatin receptor 4 |
|
decreases expression |
ISO |
3 |
137,150,419 |
137,152,284 |
RGD:6480464 |
CTD |
| G |
Stam |
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 |
|
affects expression |
ISO |
17 |
88,276,082 |
88,321,955 |
RGD:6480464 |
CTD |
| G |
Stat2 |
signal transducer and activator of transcription 2 |
|
affects expression |
ISO |
7 |
1,564,385 |
1,580,652 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
decreases response to substance |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat4 |
signal transducer and activator of transcription 4 |
|
increases methylation |
ISO |
9 |
46,510,251 |
46,650,076 |
RGD:6480464 |
CTD |
| G |
Stk17b |
serine/threonine kinase 17b |
|
affects expression |
ISO |
9 |
52,567,310 |
52,596,817 |
RGD:6480464 |
CTD |
| G |
Stmn2 |
stathmin-like 2 |
|
decreases expression |
ISO |
2 |
95,284,903 |
95,332,686 |
RGD:6480464 |
CTD |
| G |
Stom |
stomatin |
|
decreases expression |
ISO |
3 |
14,392,978 |
14,415,288 |
RGD:6480464 |
CTD |
| G |
Stx3 |
syntaxin 3 |
|
decreases expression |
ISO |
1 |
214,554,512 |
214,597,396 |
RGD:6480464 |
CTD |
| G |
Sufu |
suppressor of fused homolog (Drosophila) |
|
increases methylation |
ISO |
1 |
251,612,377 |
251,708,109 |
RGD:6480464 |
CTD |
| G |
Sv2a |
synaptic vesicle glycoprotein 2a |
|
increases methylation |
ISO |
2 |
190,989,187 |
191,000,859 |
RGD:6480464 |
CTD |
| G |
Synj2 |
synaptojanin 2 |
|
affects expression |
ISO |
1 |
40,763,794 |
40,818,491 |
RGD:6480464 |
CTD |
| G |
T |
brachyury |
|
increases response to substance |
ISO |
1 |
46,937,223 |
46,944,988 |
RGD:6480464 |
CTD |
| G |
Taf1d |
TATA box binding protein (Tbp)-associated factor, RNA polymerase I, D |
|
decreases expression |
ISO |
8 |
12,107,144 |
12,117,177 |
RGD:6480464 |
CTD |
| G |
Tagap |
T-cell activation RhoGTPase activating protein |
|
affects expression |
ISO |
1 |
41,385,839 |
41,392,522 |
RGD:6480464 |
CTD |
| G |
Tagln |
transgelin |
|
affects expression |
ISO |
8 |
48,902,208 |
48,907,682 |
RGD:6480464 |
CTD |
| G |
Tal1 |
T-cell acute lymphocytic leukemia 1 |
|
affects expression |
ISO |
5 |
135,430,985 |
135,444,692 |
RGD:6480464 |
CTD |
| G |
Tank |
TRAF family member-associated NFKB activator |
|
multiple interactions |
ISO |
3 |
43,396,247 |
43,475,491 |
RGD:6480464 |
CTD |
| G |
Tank |
TRAF family member-associated NFKB activator |
|
decreases expression |
ISO |
3 |
43,396,247 |
43,475,491 |
RGD:6480464 |
CTD |
| G |
Tbr1 |
T-box, brain, 1 |
|
increases methylation |
ISO |
3 |
43,647,046 |
43,655,746 |
RGD:6480464 |
CTD |
| G |
Tceal3 |
transcription elongation factor A (SII)-like 3 |
|
increases methylation |
ISO |
X |
124,311,866 |
124,314,022 |
RGD:6480464 |
CTD |
| G |
Tctn3 |
tectonic family member 3 |
|
affects expression |
ISO |
1 |
245,725,786 |
245,735,594 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
increases expression |
ISO |
1 |
30,445,180 |
30,465,942 |
RGD:6480464 |
CTD |
| G |
Tesk2 |
testis-specific kinase 2 |
|
affects expression |
ISO |
5 |
137,014,118 |
137,100,429 |
RGD:6480464 |
CTD |
| G |
Tfam |
transcription factor A, mitochondrial |
|
increases expression |
ISO |
20 |
18,100,629 |
18,112,682 |
RGD:6480464 |
CTD |
| G |
Tfam |
transcription factor A, mitochondrial |
|
increases expression |
ISO |
20 |
18,100,629 |
18,112,682 |
RGD:6480464 |
CTD |
| G |
Tfdp2 |
transcription factor Dp-2 (E2F dimerization partner 2) |
|
increases expression |
ISO |
8 |
101,256,112 |
101,392,512 |
RGD:6480464 |
CTD |
| G |
Tff2 |
trefoil factor 2 |
|
increases expression |
ISO |
20 |
9,492,341 |
9,510,558 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
multiple interactions |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
decreases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
decreases expression |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
multiple interactions |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Thap11 |
THAP domain containing 11 |
|
affects expression |
ISO |
19 |
35,692,222 |
35,694,039 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
increases expression |
ISO |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Timm50 |
translocase of inner mitochondrial membrane 50 homolog (S. cerevisiae) |
|
increases methylation |
ISO |
1 |
83,399,403 |
83,400,789 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
decreases expression |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
increases expression |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tmem185a |
transmembrane protein 185A |
|
affects expression |
ISO |
X |
156,926,468 |
156,951,202 |
RGD:6480464 |
CTD |
| G |
Tmem47 |
transmembrane protein 47 |
|
decreases expression |
ISO |
X |
67,522,289 |
67,549,061 |
RGD:6480464 |
CTD |
| G |
Tmtc2 |
transmembrane and tetratricopeptide repeat containing 2 |
|
decreases expression |
ISO |
7 |
43,667,983 |
44,133,854 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects response to substance |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 |
|
multiple interactions |
ISO |
5 |
171,727,707 |
171,735,340 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
decreases expression |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
multiple interactions |
ISO |
5 |
169,344,695 |
169,348,961 |
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
decreases expression |
ISO |
5 |
169,344,695 |
169,348,961 |
RGD:6480464 |
CTD |
| G |
Tnfrsf8 |
tumor necrosis factor receptor superfamily, member 8 |
|
increases expression |
ISO |
5 |
163,716,462 |
163,762,235 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf8 |
tumor necrosis factor (ligand) superfamily, member 8 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnfsf8 |
tumor necrosis factor (ligand) superfamily, member 8 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnfsf9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnfsf9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnik |
TRAF2 and NCK interacting kinase |
|
decreases expression |
ISO |
2 |
115,599,466 |
116,003,005 |
RGD:6480464 |
CTD |
| G |
Tnnc2 |
troponin C type 2 (fast) |
|
decreases expression |
ISO |
3 |
155,807,133 |
155,808,219 |
RGD:6480464 |
CTD |
| G |
Tomm40 |
translocase of outer mitochondrial membrane 40 homolog (yeast) |
|
affects expression |
ISO |
1 |
79,008,895 |
79,020,420 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2b |
topoisomerase (DNA) II beta |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Top2b |
topoisomerase (DNA) II beta |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases mutagenesis |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases methylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53i11 |
tumor protein p53 inducible protein 11 |
|
affects expression |
ISO |
3 |
77,587,546 |
77,602,708 |
RGD:6480464 |
CTD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
increases expression |
ISO |
5 |
25,008,253 |
25,014,263 |
RGD:6480464 |
CTD |
| G |
Tpd52l2 |
tumor protein D52-like 2 |
|
increases methylation |
ISO |
3 |
170,631,625 |
170,650,377 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
decreases expression |
EXP |
4 |
160,933,341 |
160,936,871 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
affects expression |
EXP |
4 |
160,933,341 |
160,936,871 |
RGD:6480464 |
CTD |
| G |
Tpsb2 |
tryptase beta 2 |
|
affects expression |
ISO |
10 |
14,613,118 |
14,614,917 |
RGD:6480464 |
CTD |
| G |
Tra2a |
transformer 2 alpha homolog (Drosophila) |
|
decreases expression |
ISO |
4 |
77,372,546 |
77,391,417 |
RGD:6480464 |
CTD |
| G |
Traf2 |
Tnf receptor-associated factor 2 |
|
multiple interactions |
ISO |
3 |
3,692,740 |
3,717,332 |
RGD:6480464 |
CTD |
| G |
Traf6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
3 |
86,827,582 |
86,847,408 |
RGD:6480464 |
CTD |
| G |
Trappc10 |
trafficking protein particle complex 10 |
|
decreases expression |
ISO |
20 |
10,774,972 |
10,833,551 |
RGD:6480464 |
CTD |
| G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
|
decreases expression |
ISO |
9 |
8,175,081 |
8,186,142 |
RGD:6480464 |
CTD |
| G |
Trem3 |
triggering receptor expressed on myeloid cells 3 |
|
decreases expression |
ISO |
9 |
8,161,126 |
8,171,287 |
RGD:6480464 |
CTD |
| G |
Trim29 |
tripartite motif-containing 29 |
|
increases methylation |
ISO |
8 |
46,312,645 |
46,337,389 |
RGD:6480464 |
CTD |
| G |
Tsc22d3 |
TSC22 domain family, member 3 |
|
increases methylation |
ISO |
X |
128,336,408 |
128,340,027 |
RGD:6480464 |
CTD |
| G |
Tsc22d3 |
TSC22 domain family, member 3 |
|
decreases expression |
ISO |
X |
128,336,408 |
128,340,027 |
RGD:6480464 |
CTD |
| G |
Tslp |
thymic stromal lymphopoietin |
|
decreases expression |
ISO |
18 |
25,268,082 |
25,274,214 |
RGD:6480464 |
CTD |
| G |
Tspan7 |
tetraspanin 7 |
|
decreases expression |
ISO |
X |
24,362,332 |
24,383,176 |
RGD:6480464 |
CTD |
| G |
Ttc7a |
tetratricopeptide repeat domain 7A |
|
affects expression |
ISO |
6 |
10,787,530 |
10,895,027 |
RGD:6480464 |
CTD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
19 |
26,527,548 |
26,535,621 |
RGD:6480464 |
CTD |
| G |
Upk1b |
uroplakin 1B |
|
decreases expression |
ISO |
11 |
63,729,052 |
63,767,358 |
RGD:6480464 |
CTD |
| G |
Uqcrc1 |
ubiquinol-cytochrome c reductase core protein I |
|
increases expression |
ISO |
8 |
113,955,930 |
113,967,675 |
RGD:6480464 |
CTD |
| G |
Uso1 |
USO1 vesicle transport factor |
|
decreases expression |
ISO |
14 |
17,414,403 |
17,480,241 |
RGD:6480464 |
CTD |
| G |
Usp13 |
ubiquitin specific peptidase 13 |
|
decreases expression |
ISO |
2 |
119,006,687 |
119,116,188 |
RGD:6480464 |
CTD |
| G |
Usp44 |
ubiquitin specific peptidase 44 |
|
increases methylation |
ISO |
7 |
30,898,472 |
30,971,342 |
RGD:6480464 |
CTD |
| G |
Uvssa |
UV-stimulated scaffold protein A |
|
increases methylation |
ISO |
14 |
83,163,555 |
83,199,401 |
RGD:6480464 |
CTD |
| G |
Vamp5 |
vesicle-associated membrane protein 5 |
|
affects expression |
ISO |
4 |
105,673,889 |
105,674,892 |
RGD:6480464 |
CTD |
| G |
Vash1 |
vasohibin 1 |
|
affects expression |
ISO |
6 |
110,806,294 |
110,818,161 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vegfb |
vascular endothelial growth factor B |
|
affects expression |
ISO |
1 |
209,657,632 |
209,661,271 |
RGD:6480464 |
CTD |
| G |
Vegfb |
vascular endothelial growth factor B |
|
increases expression |
ISO |
1 |
209,657,632 |
209,661,271 |
RGD:6480464 |
CTD |
| G |
Vegfc |
vascular endothelial growth factor C |
|
decreases expression |
ISO |
16 |
40,624,435 |
40,739,692 |
RGD:6480464 |
CTD |
| G |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
|
affects expression |
ISO |
2 |
155,875,542 |
156,139,651 |
RGD:6480464 |
CTD |
| G |
Wars2 |
tryptophanyl tRNA synthetase 2 (mitochondrial) |
|
increases methylation |
ISO |
2 |
193,819,862 |
193,902,421 |
RGD:6480464 |
CTD |
| G |
Wdr16 |
WD repeat domain 16 |
|
decreases expression |
ISO |
10 |
54,657,453 |
54,699,729 |
RGD:6480464 |
CTD |
| G |
Wdr26 |
WD repeat domain 26 |
|
affects expression |
ISO |
13 |
96,944,266 |
96,984,348 |
RGD:6480464 |
CTD |
| G |
Wdr34 |
WD repeat domain 34 |
|
affects expression |
ISO |
3 |
9,021,833 |
9,037,243 |
RGD:6480464 |
CTD |
| G |
Wdr88 |
WD repeat domain 88 |
|
increases methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Wnk1 |
WNK lysine deficient protein kinase 1 |
|
decreases expression |
ISO |
4 |
156,297,841 |
156,421,820 |
RGD:6480464 |
CTD |
| G |
Wnt10a |
wingless-type MMTV integration site family, member 10A |
|
affects expression |
ISO |
9 |
74,124,403 |
74,137,508 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
multiple interactions |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
affects response to substance |
ISO |
5 |
62,706,719 |
62,750,771 |
RGD:6480464 |
CTD |
| G |
Xpc |
xeroderma pigmentosum, complementation group C |
|
affects expression |
ISO |
4 |
125,672,674 |
125,699,925 |
RGD:6480464 |
CTD |
| G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
increases expression |
ISO |
1 |
79,834,167 |
79,860,300 |
RGD:6480464 |
CTD |
| G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
decreases expression |
ISO |
1 |
79,834,167 |
79,860,300 |
RGD:6480464 |
CTD |
| G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
multiple interactions |
ISO |
1 |
79,834,167 |
79,860,300 |
RGD:6480464 |
CTD |
| G |
Xrcc3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
affects response to substance |
ISO |
6 |
136,594,276 |
136,602,069 |
RGD:6480464 |
CTD |
| G |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
decreases expression |
ISO |
2 |
19,904,490 |
20,158,358 |
RGD:6480464 |
CTD |
| G |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
multiple interactions |
ISO |
2 |
19,904,490 |
20,158,358 |
RGD:6480464 |
CTD |
| G |
Ybx2 |
Y box binding protein 2 |
|
increases methylation |
ISO |
10 |
56,780,431 |
56,786,061 |
RGD:6480464 |
CTD |
| G |
Ypel1 |
yippee-like 1 (Drosophila) |
|
affects expression |
ISO |
11 |
85,929,479 |
85,936,364 |
RGD:6480464 |
CTD |
| G |
Zbtb10 |
zinc finger and BTB domain containing 10 |
|
affects expression |
ISO |
2 |
94,538,617 |
94,569,036 |
RGD:6480464 |
CTD |
| G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
|
decreases expression |
ISO |
8 |
51,931,530 |
52,094,813 |
RGD:6480464 |
CTD |
| G |
Zbtb25 |
zinc finger and BTB domain containing 25 |
|
affects expression |
ISO |
6 |
98,947,494 |
98,956,229 |
RGD:6480464 |
CTD |
| G |
Zbtb8a |
zinc finger and BTB domain containing 8a |
|
increases methylation |
ISO |
5 |
148,510,151 |
148,538,267 |
RGD:6480464 |
CTD |
| G |
Zcchc2 |
zinc finger, CCHC domain containing 2 |
|
increases expression |
ISO |
13 |
12,148,072 |
12,196,570 |
RGD:6480464 |
CTD |
| G |
Zeb2 |
zinc finger E-box binding homeobox 2 |
|
affects expression |
ISO |
3 |
25,513,009 |
25,654,964 |
RGD:6480464 |
CTD |
| G |
Zeb2 |
zinc finger E-box binding homeobox 2 |
|
decreases expression |
ISO |
3 |
25,513,009 |
25,654,964 |
RGD:6480464 |
CTD |
| G |
Zfand6 |
zinc finger, AN1-type domain 6 |
|
decreases expression |
ISO |
1 |
140,885,701 |
140,960,486 |
RGD:6480464 |
CTD |
| G |
Zfc3h1 |
zinc finger, C3H1-type containing |
|
affects expression |
ISO |
7 |
54,655,964 |
54,713,947 |
RGD:6480464 |
CTD |
| G |
Zfp260 |
zinc finger protein 260 |
|
decreases expression |
ISO |
1 |
85,141,167 |
85,144,447 |
RGD:6480464 |
CTD |
| G |
Zfp414 |
zinc finger protein 414 |
|
increases methylation |
ISO |
7 |
16,131,618 |
16,134,227 |
RGD:6480464 |
CTD |
| G |
Zfp524 |
zinc finger protein 524 |
|
increases methylation |
ISO |
1 |
67,563,455 |
67,564,503 |
RGD:6480464 |
CTD |
| G |
Zfp579 |
zinc finger protein 579 |
|
affects expression |
ISO |
1 |
67,586,226 |
67,589,398 |
RGD:6480464 |
CTD |
| G |
Zfp711 |
zinc finger protein 711 |
|
decreases expression |
ISO |
X |
101,187,139 |
101,215,168 |
RGD:6480464 |
CTD |
| G |
Zfp771 |
zinc finger protein 771 |
|
affects expression |
ISO |
1 |
186,506,270 |
186,517,652 |
RGD:6480464 |
CTD |
| G |
Zswim2 |
zinc finger, SWIM-type containing 2 |
|
increases methylation |
ISO |
3 |
67,101,242 |
67,121,620 |
RGD:6480464 |
CTD |
Term paths to the root
|